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Transient receptor potential vanilloid subtype 1 (TRPV1) is predominantly 
expressed in central terminals of C-fiber primary sensory neuron and their 
antagonists have shown efficacy in inflammatory and neuropathic pain. TRPV1 
and metabotropic glutamate receptor 5 (mGluR5) located on peripheral sensory 
terminals have been shown to play critical roles in the transduction and 
modulation of pain sensation. However, very little is known regarding the 
significance of functional expression of mGluR5 and TRPV1 on the central 
terminals of sensory neurons in the dorsal horn of the spinal cord.  
In the first chapter, I show that functional coupling of mGluR5-TRPV1 via 
diacylglycerol (DAG) generated by mGluR5 activation on the central 
presynaptic terminals of nociceptive neurons may be an important mechanism 
underlying central sensitization under pathological pain conditions.  
A number of recent studies revealed that TRPV1 antagonist attenuated not 
only thermal hyperalgesia but also mechanical allodynia, which is thought to be 
independent of peripheral-TRPV1, suggesting that central postsynaptic TRPV1 
may be involved in pathological mechanical pain. However, the underlying 
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mechanisms for the activation of central TRPV1 and role of central 
postsynaptic TRPV1 under pathophysiological conditions remain unknown.  
In the second chapter, I present that activation of spinal TRPV1 induces 
long-term depression (LTD) in GABAergic substantia gelatinosa (SG) neurons 
and produces mechanical allodynia by reducing inhibitory inputs to projection 
neurons. Chronic mechanical pain following nerve injury was reversed by a 
spinally applied TRPV1 antagonist. Taken together, spinal TRPV1 plays a 
critical role as a synaptic regulator and suggest the utility of CNS-specific 
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1. Transient receptor potential vanilloid 1 (TRPV1) 
The transient receptor potential cation channel subfamily V member 1 
(TRPV1), also known as the capsaicin receptor and the vanilloid receptor 1, 
was initially tested using capsaicin without their molecular identities in 
peripheral neuron. Capsaicin induced currents were first reported by Bevan and 
Szolcsanyi (Bevan and Szolcsanyi, 1990). Capsaicin induces inward currents in 
a dose dependent manner and reverses at a membrane potential of 0 mV, 
suggesting that capsaicin activates a nonselective cation channel (Bevan and 
Szolcsanyi, 1990; Urban and Dray, 1993). Single-channel conductance of 
capsaicin activated channels was much greater at a membrane potential of + 60 
mV than – 60 mV and their open probability were increased by membrane 
depolarization (Oh et al., 1996), suggesting capsaicin induced currents are 
outwardly rectifying and potentially voltage dependent (Piper et al., 1999; 
Gunthorpe et al., 2000).  
In 1997, the first vanilloid (capsaicin) receptor, TRPV1 was cloned by David 
Julius and colleagues (Caterina et al., 1997). TRPV1 encoding an 838 amino 
acid protein (~95 kDa) has putative six transmembrane domains with pore-
forming hydrophobic region between the fifth and sixth transmembrane 
domains and two intracellular cytosolic tails in N- and C-termini with three 
ankyrin repeats in the N‐terminus (Caterina et al., 1997; Szallasi et al., 2007).  
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2. Mechanisms of TRPV1 activation 
TRPV1 is activated not only by vanilloids, such as capsaicin, but also by 
noxious heat (>43°C) and low pH (Caterina et al., 1997; Tominaga et al., 1998), 
ethanol (Caterina et al., 1997; Trevisani et al., 2002) and various lipids 
metabolites including N-arachidonoyl-ethanolamine (anandamide), N-
arachidonoyl-dopamine, N-oleoyldopamine, lipoxygenase products, such 12- 
and 15(S)-hydroperoxyeicosatetraenoic acid (12-(S)-HPETE and 15-(S)-
HPETE), 5- and 15-(S)-hydroxyeicosatetraenoic acids (5-(S)-HETE, 15-(S)-
HETE) (Zygmunt et al., 1999; Hwang et al., 2000; Kwak et al., 2000; Caterina 
and Julius, 2001; Huang et al., 2002; Shin et al., 2002; Bhave et al., 2003; Chu 
et al., 2003).  
Intracellular capsaicin binding sites of TRPV1 has been confirmed using a 
synthetic water-soluble capsaicin analogue DA‐5018, which is membrane 
impermeable (Jung et al., 1999). Several key residues of TRPV1 for binding of 
capsaicin and other agonists have been identified using comparison of TRPV1 
channel response to distinct agonists and their sequence alignment throughout 
different species (Jordt and Julius, 2002; Correll et al., 2004; Phillips et al., 
2004; Ohta et al., 2005; Sutton et al., 2005). Avian TRPV1 ortholog was cloned 
from chicken DRG which was insensitive to capsaicin but had a normal 
response to heat and low pH. Multiple sequence analysis revealed that avian 
TRPV1 and rat TRPV1 have a number of differences in the TM2 and TM4 
domains. Using point-mutagenesis of the rat TRPV1, the essential role of Y511 
and adjacent S512 for capsaicin response was confirmed, whereas heat- and 
pH-induced response remained (Jordt and Julius, 2002).  
Acidification of the extracellular condition (pH<6.0) can leads to channel 
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activation probably through different opening mechanism from capsaicin. 
Extracellular proton elicited TRPV1 channel current when applied to outside-
out manner, but not in inside-out manner (Tominaga et al., 1998). Site-directed 
mutagenesis revealed that Glu 648 in extracellular domain is a crucial site for 
proton-induced TRPV1 activation. In addition, Glu 600 in extracellular domain 
has a role of proton-induced potentiation of TRPV1 activity (Jordt et al., 2000), 
suggesting that protons act on the extracellular domain of TRPV1 for 
modulation and activation of TRPV1.  
Since TRPV1, first thermo-TRP channel, was found, several thermo-TRP 
ion channels were identified, which include TRPV2, TRPV3, TRPV4, TRPM8 
and TRPA1, suggesting that temperature sensor domains are present in these 
TRP ion channel family proteins (Caterina et al., 1999; Peier et al., 2002a; Peier 
et al., 2002b; Story et al., 2003; Chung et al., 2004). Although key residues of 
selective heat-sensing site in thermo-TRP channel have not been found, heat-
induced TRPV1 single-channel conductance was observed using inside-out 
membrane patches demonstrating that TRPV1 is a direct heat sensor (Tominaga 
et al., 1998). A few potential candidates of heat-sensing domain were suggested 
that C-terminal cytoplasmic tail and voltage-dependent domain of TRPV1 may 
be involved in thermo-sensing activity (Vlachova et al., 2003; Voets et al., 
2004). 
 
3. TRPV1 in nociception 
TRPV1 receptors are strongly expressed in the peripheral nervous system 
(PNS) including C polymodal nociceptive and Aδ nociceptive primary afferent 
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terminals (Michael and Priestley, 1999; Guo et al., 2001; Valtschanoff et al., 
2001). TRPV1 in primary afferent terminals can detect noxious heat and convey 
painful signals to avoid potential tissue damage. In physiological condition, 
TRPV1 deficient mice showed an impaired pain nociception by acute thermal 
stimuli (Caterina et al., 2000; Davis et al., 2000). In inflammation, increased 
heat sensitivity was normally observed. Using mice model of inflammation 
induced by Complete Freund’s Adjuvant (CFA) and carrageenan, TRPV1 
deficient mice exhibited relatively less thermal hypersensitivity (Caterina et al., 
2000; Davis et al., 2000) suggesting that inflammation potentiates TRPV1 
activity in nociceptive neurons.  
A number of inflammatory mediators involved in TRPV1 sensitization have 
been reported, which include bradykinin, adenosine 5’-triphosphate (ATP), 
nerve growth factor (NGF) and prostaglandins (Caterina et al., 2000; Davis et 
al., 2000; Chuang et al., 2001; Moriyama et al., 2003; Bolcskei et al., 2005; 
Moriyama et al., 2005). The inflammatory mediators bind to G-protein-coupled 
receptor (GPCR), which activates PKA- (De Petrocellis et al., 2001; Bhave et 
al., 2002; Rathee et al., 2002) and PKC-pathways (Premkumar and Ahern, 2000; 
Sugiura et al., 2002) to phosphorylate TRPV1.  
PKA-dependent phosphorylation at Ser 116, Thr 144, Thr 370 and Ser 502 
residues of TRPV1 play an important role in the development of hyperalgesia 
by inhibiting TRPV1 desensitization (Bhave et al., 2002; Mohapatra and Nau, 
2003) and sensitizing heat-evoked TRPV1 responses (Rathee et al., 2002). Also, 
PKC-dependent phosphorylation at Ser 502 and Ser 800 residues of TRPV1 can 
sensitize TRPV1 activity induced by heat, capsaicin and proton (Numazaki et 
al., 2002; Bhave et al., 2003). Furthermore, these TRPV1 phosphorylation can 
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facilitate TRPV1 trafficking to the plasma membrane (Zhang et al., 2005). In 
addition, NGF induced hyperalgesia by both increasing trafficking level of 
TRPV1 channels in neuronal membrane (Morenilla-Palao et al., 2004; Zhang et 
al., 2005) and upregulating the expression level of TRPV1 (Ji et al., 2002; 
Puntambekar et al., 2005).  
 
4. Substantia gelatinosa (SG) in nociceptive processing 
The substantia gelatinosa (SG) of the spinal dorsal horn in lamina II receives 
central inputs of heavily myelinated Aδ-fibers carrying innocuous mechanical 
stimuli, lightly myelinated Aδ-fibers and unmyelinated c-fibers carrying 
noxious, temperature and itch sensations (Woolf and Fitzgerald, 1983; 
Yoshimura and Jessell, 1989). Interestingly, TRPV1 is predominantly expressed 
in central terminals of C-fiber primary sensory neuron in lamina I-II of the 
spinal cord. 
The SG is the first synaptic area of nociceptive signaling via projection 
neurons to higher brain centers. SG neurons have been classified into at least 
four different types by morphology based on orientation and position of cell 
soma, dendrites and axons; vertical, radial, islet and central cells (Todd and 
Spike, 1993; Yasaka et al., 2007). Prominent proportion of the local circuitry in 
SG is inhibitory connection of GABAergic neurons and glycinergic neurons 
(Todd and McKenzie, 1989; Todd and Sullivan, 1990). These inhibitory 
interneurons have been proposed as a gate of pain transmission and other 
sensory modalities to the higher brain centers (Melzack and Wall, 1965). It has 
also been proved that inhibition of spinal cord, especially dorsal horn, is very 
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important to prevent developing hyperalgesia and allodynia (Yaksh, 1989; 
Sivilotti and Woolf, 1994), indicating that tonic inhibition via GABA receptors 
and glycine receptors is necessary for maintaining normal sensory responses.  
 
5. Central sensitization of the spinal cord 
Central sensitization is an increase in neuronal excitability within the central 
nervous system, so that innocuous stimuli become perceived as pain (Woolf et 
al., 1992). The increased neuronal excitability is generated by periperal 
nociceptors of injured- or inflamed site. Continuous nociceptive inputs from 
PNS can alter the strength of synaptic efficacy in the spinal circuits via synaptic 
facilitation or a reduction in inhibition (Woolf and Salter, 2000), leading to 
increase the gain of nociception and maintaining a chronic pain state (Campbell 
and Meyer, 2006). The early changes in synaptic connectivity are caused by 
excessive releasing of transmitters or modulators such as glutamate and 
neuropeptides, which induces synaptic receptors phosphorylation (Ultenius et 
al., 2006) and enhances channel trafficking to synapse in the post-synpatic 
neurons (Iwata et al., 2007). In addition, a loss of GABAergic inhibition in the 
spinal cord through microglial BDNF induced down-regulation of the 
potassium chloride cotransporter 2 (KCC2) (Coull et al., 2005) and cell death of 
spinal inhibitory neurons (Scholz et al., 2005) contributes to pain 
hypersensitivity. 
Recent studies have shown that TRPV1 receptors are also expressed in 
several regions of the CNS including brain regions such as the hippocampus as 
well as the spinal dorsal horn (Valtschanoff et al., 2001; Gibson et al., 2008). 
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Interestingly, TRPV1 immunoreactivity in the spinal dorsal horn is partly due to 
existence of postsynaptic TRPV1 and neurotransmission in superficial dorsal 
horn is modulated by TRPV1 agonists after dorsal rhizotomy (Valtschanoff et 
al., 2001; Zhou et al., 2009). Furthermore, TRPV1-mediated increases in 
neurotransmitter release from nociceptive primary afferent terminals in spinal 
cord has been reported (Yang et al., 1998; Sikand and Premkumar, 2007). Thus, 
TRPV1 activation in both primary afferent terminals and spinal neurons may 
affect to synaptic transmission of the spinal cord.  
Consistently, spinal TRPV1 activation can cause mechanical allodynia via 
central sensitization (Patwardhan et al., 2009) and spinal administration of 
TRPV1 antagonists can attenuate both inflammatory and neuropathic 
mechanical pain (Patapoutian et al., 2009), suggesting that TRPV1 may 
contribute to pain hypersensitivity under pathological pain conditions (Caterina 
et al., 2000; Kanai et al., 2006). However, distinct roles and molecular 
mechanisms for presynaptic and postsynaptic TRPV1 action in pain 







In this thesis study, I have explored the role of TRPV1 in the spinal cord 
nociceptive circuitry. Further, I have investigated its contribution to the 
enhancement of pain sensitivity through presynaptic mechanism in central 
terminals of nociceptive primary afferent neurons and postsynaptic mechanism 
in SG neurons of spinal cord. To address these mechanisms, the experiments 
were performed following specific aims.  
 
 To characterize the mechanism of TRPV1 activation in the spinal cord, 
especially in nociceptive primary afferent terminal. 
 To confirm whether TRPV1 is expressed in spinal cord neurons. If so, 
what is the role of spinal TRPV1 in these neurons? 




CHAPTER 1:     
Membrane-Delimited Coupling of 
TRPV1 and mGluR5 on 






Transient receptor potential vanilloid subtype 1 (TRPV1) and metabotropic 
glutamate receptor 5 (mGluR5) located on peripheral sensory terminals have 
been shown to play critical roles in the transduction and modulation of pain 
sensation. To date, however, very little is known regarding the significance of 
functional expression of mGluR5 and TRPV1 on the central terminals of 
sensory neurons in the dorsal horn of the spinal cord. Here I show that TRPV1 
on central presynaptic terminals is coupled to mGluR5 in a membrane-
delimited manner, thereby contributing to the modulation of nociceptive 
synaptic transmission in the substantia gelatinosa (SG) neurons of the spinal 
cord. Further, the present results demonstrate that TRPV1 is involved in the 
pain behaviors induced by spinal mGluR5 activation, and diacylglycerol (DAG) 
produced by the activation of mGluR5 mediates functional coupling of mGluR5 
and TRPV1 on the presynaptic terminals. Thus, mGluR5-TRPV1 coupling on 
the central presynaptic terminals of nociceptive neurons may be an important 







Peripheral TRPV1 is activated not only by capsaicin, heat, and acid 
(Caterina et al., 1997; Tominaga et al., 1998; Szallasi and Blumberg, 1999; 
Clapham, 2003) but also by inflammatory mediator-related molecules including 
the products of lipoxygenases, anandamide, and other endocannabinoids 
(Hwang et al., 2000; Julius and Basbaum, 2001; Ralevic et al., 2001; Di Marzo 
et al., 2002; van der Stelt et al., 2005). Multiple inflammatory mediators have 
been shown to heighten the sensitivity of nociceptive sensory neurons after 
binding to their respective G-protein coupled receptors (GPCRs) (Scholz and 
Woolf, 2002), leading to inflammation-induced thermal hyperalgesia via 
TRPV1. Group I metabotropic glutamate receptors (especially mGluR5) are 
expressed together with TRPV1 in dorsal root ganglion (DRG) neurons (Walker 
et al., 2001a) and are also involved in peripheral sensitization of sensory 
neurons via G-protein mediated TRPV1 modulation (Huang et al., 2002).  
Notably, both mGluR5 and TRPV1 are expressed on the central terminals of 
primary afferents in the superficial lamina of the spinal dorsal horn, the key site 
for the transmission of pain sensation (Jia et al., 1999; Valtschanoff et al., 2001). 
Capsaicin potently increases the frequency, but not the amplitude, of mEPSCs 
in a DRG-dorsal horn neuronal co-culture system (Sikand and Premkumar, 
2007), as well as in a spinal slice condition (Yang et al., 1998), suggesting that 
TRPV1-mediated neurotransmitter release from presynaptic terminals of 
nociceptive neurons contributes to nociceptive transmission. Despite these 
findings, however, the underlying mechanisms for the activation of central 
presynaptic TRPV1 under pathophysiological conditions remain unknown 
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(Patapoutian et al., 2009).   
It is well-known that the modulation of synaptic transmissions in the 
superficial dorsal horn contributes to the pathophysiology of chronic pain 
conditions (Woolf and Salter, 2000). Indeed, both spinal mGluR5 and TRPV1 
have been demonstrated to contribute to pain hypersensitivity under 
pathological pain conditions (Caterina et al., 2000; Walker et al., 2001b; Zhu et 
al., 2005; Kanai et al., 2006). While a functional role for mGluR5 in superficial 
dorsal horn neurons (i.e. postsynaptic neurons) has recently been demonstrated 
(Hu et al., 2007), relatively little is known about how presynaptic mGluR5 
contributes to nociceptive synaptic transmissions in the spinal dorsal horn.  
In the present study, I hypothesized that mGluR5 and TRPV1 are coupled on 
the central presynaptic terminals of nociceptive neurons, thereby contributing to 
the pain transmission processing activity exerted by TRPV1. I attempted to 
elucidate the underlying mechanisms of TRPV1 modulation by mGluR5 
activation, as this will likely provide insight into the functional significance of 
TRPV1 expression in the central nervous system (CNS).  
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MATERIALS AND METHODS 
 
All surgical and experimental procedures were reviewed and approved by 
the Institutional Animal Care and Use Committee at the School of Dentistry, 
Seoul National University.  
 
Behavioral studies  
All animals were placed in an observation chamber (60 × 100 × 60 mm each) 
and allowed to habituate. A mirror was positioned behind the observation 
chamber to provide an unobstructed view. Spontaneous pain behaviors were 
assessed by measuring the time each animal spent flinching, licking and/or 
biting its hindpaws or tail. The cumulative time spent flinching, licking or 
biting hindpaws or tails during a 5 min period was recorded immediately prior 
to drug administration and then again up to 210 min after drug administration. 
For mechanical sensitivity (von Frey filaments) testing, mice were brought 
from the animal colony and placed in transparent plastic boxes (60 × 100 × 60 
mm) on a metal mesh floor (3 × 3 mm mesh). The mice were then left alone for 
at least 20 min to allow them to acclimate prior to testing. To assess mechanical 
sensitivities, the withdrawal threshold of the hindpaw was measured using a 
series of von Frey filaments (0.20, 0.69, 1.57, 3.92, 5.88, 9.80, 19.60 and 39.20 
mN, Stoelting, Wood Dale, IL, USA; equivalent in grams to 0.02, 0.07, 0.16, 
0.40, 0.60, 1.0, 2.0 and 4.0). The 50% withdrawal threshold was determined 
using the up-down method as previously described (Chaplan et al., 1994). A 
brisk hindpaw lift in response to von Frey filament stimulation was regarded as 
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a withdrawal response. The 0.4 g filament was the first stimulus to be used, and, 
when a withdrawal response was obtained, the next weaker filament was used. 
This process was repeated until no response was obtained, at which time the 
next stronger filament was administered. Interpolation of the 50% threshold 
was then carried out using the method of Dixon (Dixon, 1980). All behavioral 
testing was performed by an investigator who was blind to the genetic 
background of the mice. 
 
Intrathecal injection of Drug 
(R,S)-3,5-dihydroxyphenylglycine (DHPG) was dissolved in 0.9% saline 
using an ultrasonic washer and applied intrathecally. The dose used in this study 
was 15 nmol. Intrathecal administration was performed as described previously 
(Hylden and Wilcox, 1980). Briefly, under slight enflurane anesthesia (2% in 95% 
O2), the vertebral column of mouse was held using the thumb and middle finger 
of the left hand and the drug was injected intrathecally into each mouse using a 
25 μl Hamilton syringe fitted with 31 gauge needle at approximately the lumbar 
enlargement level of the spinal cord. The injection volume was 5 μl and the 
injection sites were verified by injecting a similar volume of 1% methylene blue 
solution and determining the distribution of the injected dye in the spinal cord. 
Before conducting experiments, the injection method was practiced until the 
success rate was consistently over 95%.  
 
DRG preparation 
DRG neurons obtained from 4- to 7-day-old neonatal rats were prepared as 
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previously described (Oh et al., 2001). Briefly, animals were decapitated, and 
DRGs were rapidly removed under aseptic conditions and placed in HBSS 
(Welgene, Korea). DRGs were digested in 1 mg/ml collagenase A (Roche) and 
2.4 unit/ml dispase II (Roche) in HBSS for 10 min respectively, followed by 20 
min in 0.125% trypsin (Sigma), all at 37°C. The DRGs were then washed in 
DMEM (Welgene, Korea) 3 times and resuspended in F12 media supplemented 
with 10% FBS (Gibco) and 1% penicillin/ streptomycin (Sigma). DRGs were 
then mechanically dissociated using fire-polished glass pipettes, centrifuged 
(800 RPM, 5 min), resuspended in F12 media supplemented with 5% FBS 
(Gibco), 20 ng/ml NGF (Invitrogen), 1X N-2 supplement (Invitrogen) and 1% 
penicillin/ streptomycin (Gibco), and plated on 0.5 mg/ml poly-L-ornithine 
(Sigma) coated glass coverslips. Cells were maintained at 37°C in 5% CO2 
incubator. 
 
Cell culture and transient transfection 
Human embryonic kidney (HEK)-293 cells (American Type Culture 
Collection, Manassas, VA) were maintained according to the supplier’s 
recommendations. For transient transfections, cells were seeded in 12-well 
plates. The next day, the cells were transfected with 1 μg/well of pcDNA 
expression vectors for TRPV1, TRPV1 mutants, or mGluR5 using the 
lipofectamine 2000 transfection reagent (Invitrogen) according to the 
manufacturer’s suggested protocol. After 18 - 24 hr, cells were trypsinized and 




I performed fura-2 AM-based (Molecular Probes, Eugene, OR, USA) Ca2+ 
imaging experiments as previously described (Park et al., 2006). Briefly, the 
HEK293 cells and DRG neurons prepared were loaded with fura-2 AM (2 μM) 
for 40 min at 37°C in a balanced salt solution [BSS; containing (in mM): 140 
NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 N-[2-hydroxyethyl]piperazine-N'-[2-
ethanesulfonic acid] (HEPES), 10 glucose, adjusted to pH 7.3 with NaOH]. 
Then the cells were rinsed with BSS and incubated in BSS for an additional 30 
min to de-esterify the dye. Cells on slides were placed onto an inverted 
microscope and illuminated with a 175W xenon arc lamp; excitation 
wavelengths (340/380nm) were selected by a monochromator wavelength 
changer. Intracellular calcium concentrations ([Ca2+]i) were measured by digital 
video microfluorometry with an intensified CCD camera (CasCade, Roper 
Scientific, Trenton, NJ, USA) coupled to the microscope and a computer with 
Metafluor software (Universal Imaging Corp., PA, USA). All drugs were 
applied via bath perfusion at a flow rate of 5 ml/min. 
 
Electrophysiology  
Whole-cell patch clamp recordings from DRG neurons and spinal SG 
neurons were performed at room temperature (23 ± 1°C) in normal Tyrode 
solution as previously described (Oh et al., 2001; Jung et al., 2006). Whole-cell 
currents from DRG neurons were recorded from 4- to 7-day-old Sprague–
Dawley rats (OrientBio, Korea). Whole-cell currents were recorded using an 
EPC-10 amplifier and Pulse 8.30 software (both from HEKA, Germany). Patch 
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pipettes were made from borosilicate glass and had resistances of 3 - 5 MΩ 
when filled with standard intracellular solutions. For whole-cell recordings in 
DRG neurons, I used an external bath solution (normal Tyrode solution) of the 
following composition (in mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 
glucose, and 10 HEPES, adjusted to pH 7.4 with NaOH. The pipette solution 
contained (in mM) 126 K-gluconate, 10 NaCl, 1 MgCl2, 10 EGTA, 2 NaATP, 
0.1 MgGTP, adjusted to pH 7.3 with KOH, and 295 - 300 mOsm. All drug 
solutions were applied to cells by local perfusion through a capillary tube 
(1.1 mm inner diameter) positioned near the cell of interest. The solution flow 
was driven by gravity (flow rate, 4 - 5 ml/min) and controlled by miniature 
solenoid valves (The Lee Company, Westbrook, CT). For slice patch clamp 
recordings, Sprague–Dawley rats of both sexes aged 8 - 12 days were used. 
Before decapitation, the animals were deeply anesthetized with halothane. The 
spinal cord was exposed by a dorsal laminectomy and dissected out. The 
lumbosacral segment of spinal cord was placed into ice-cold artificial 
cerebrospinal fluid (aCSF) and was attached to agarose block (3% in aCSF). 
Transverse slices (350 - 400 　m thick) of the lumbar spinal cord were obtained 
(VIBRATOME 1000 Plus) and then transferred in aCSF (in mM): 130 NaCl, 3 
KCl, 2.5 CaCl2, 1.5 MgSO4, 1.25 NaH2PO4, 25 NaHCO3, 1.25 Hepes, 10 
glucose, 20 sucrose, adjusted to pH 7.3, and 310 - 315 mOsm, equilibrated with 
95% O2 and 5% CO2) for recovery period of at least 1 hr and then maintained at 
room temperature in aCSF. The membrane currents were recorded using an 
EPC-10 amplifier and Pulse 8.30 software. A single slice was placed in a 
perfusion chamber (0.5 ml volume) and continuously superfused with 
extracellular solution (3 ml/min) saturated with 95% O2 and 5% CO2. The 
recording electrodes were filled with a solution containing (in mM); 126 K-
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gluconate, 10 NaCl, 1 MgCl2, 10 EGTA, 2 NaATP, 0.1 MgGTP, adjusted to pH 
7.3 with KOH, and 295 - 300 mOsm. Whole-cell patch-clamp recordings were 
made with thin-walled borosilicate glass unpolished pipettes (5 - 7 MΩ) from 
visually identified SG neurons in the spinal cord slice by using a fixed-stage 
microscope (BX50WI, Olympus, Japan) with Nomarski optics and a 40× water-
immersion objective. All recordings were performed at a holding potential (Vh) 
of -60 mV. mEPSCs were recorded in the presence of 0.5 μM tetrodotoxin 
(TTX), 5 μM bicuculline, and 2 μM strychnine to block voltage-dependent Na+ 
channels and activity-dependent sEPSCs, and synaptic inhibition mediated by 
GABAA and glycine receptors, respectively. Four-minute stretches of data were 
used for mEPSC frequency/amplitude analysis. The amplitude threshold for 
detection of mEPSC was set above the noise level (5 pA) and events were 
subsequently verified visually. No attempt was made to group the events by the 
rise time. The Kolmogorov–Smirnov test was used to assess the effects of the 
DHPG and capsazepine on amplitude and inter-event interval. For cell-attached 
patch clamp recordings, the recording pipette (6 - 7 MΩ) contained bath 
solution containing (in mM); 140 NaCl, 5 KCl, 1 MgCl2, 10 glucose, 2 ethylene 
glycol tetraacetic acid (EGTA) and 10 HEPES, adjusted to pH 7.4 with NaOH. 
The recordings were performed at a command potential of +40 mV.  Drugs 
were applied into recording pipette or through bath solution. All data were 
analyzed using single channel analysis program QuB software.  
 
Constructs  
An expression vector for TRPV1 containing the point mutation Y511A was 
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DHPG, (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG), 5’-
iodoresiniferatoxin (IRTX), 6-iodonordihydrocapsaicin, 7-
(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester  
(CPCCOEt), 2-Methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP), 
staurosporine, and TTX were purchased from Tocris Bioscience (Ellisville, 
MO). Capsaicin, capsazepine, thapsigargin, bicuculline, stychinin, 
bisindolylmaleimide (BIM), 1-Oleoyl-2-acetyl-sn-glycerol (OAG), 1,6-
bis(Cyclohexyloximinocarbonylamino) hexane (RHC80267), 1-[6-[((17β)-3-
Methoxyestra-1,3,5[10]-trien-17-yl)amino]hexyl]-1H-pyrrole-2,5-dione 
(U73122), and 1-[6-[((17β)-3-Methoxyestra-1,3,5[10]-trien-17-
yl)amino]hexyl]-2,5-pyrrolidinedione (U73343) were purchased from Sigma 
(St. Louis, MO).  
 
Statistical Analysis 
Data are expressed as mean ± SEM. For behavioral test, statistical analyses 
of the data obtained from the drug tests were conducted with One-way repeated 
measures ANOVA followed by a pairwise comparison of pain behaviors before 
and after the injection, utilizing Bonferroni t-test Method. Student’s t-test was 
used for the comparison between the knock-out and wild type mice and P < 
0.05 was considered statistically significant. For other studies, results were 





Coupling of group I mGluRs and TRPV1 on central terminals of sensory 
neurons contributes to pain behaviors 
It has been previously demonstrated that spontaneous pain responses are 
produced by the activation of spinal group I mGluRs (Fisher and Coderre, 1998; 
Bhave et al., 2001; Hu et al., 2007). I first investigated whether spinal TRPV1 is 
associated with the spontaneous pain behavior induced by the activation of 
spinal group I mGluRs using TRPV1 knock-out and wild-type mice. With the 
intrathecal injection of the vehicle alone, detectable changes in pain behavior 
compared with the pre-injection baseline was not observed (Figure 1A), 
suggesting marginal effects of general anesthetics on the pain behaviors 
observed in the behavioral study. In agreement with previous reports (Fisher 
and Coderre, 1998; Bhave et al., 2001; Hu et al., 2007), a single intrathecal 
injection of 15 nmol (R,S)-3,5-dihydroxyphenylglycine (DHPG), a selective 
group I mGluRs (mGluR1/5) agonist, induced an immediate and robust increase 
in wild-type mice in the time spent either flinching, licking or biting hindpaws 
or tails (**P < 0.001, *P < 0.05 vs. pre-injection baseline, one-way repeated 
measured ANOVA followed by Bonferroni t-test) (Figure 2A). I interpreted 
these responses as signs of spontaneous pain, which persisted up to 120 min 
after the injection (Figure 1). TRPV1-/- mice lacked this early manifestation of 
spontaneous pain behaviors following administration of DHPG (Figure 2A). 
Indeed, the induction of spontaneous pain behavior was markedly delayed so 
much so that the display of pain behaviors took 20 min after injection to 
become statistically significant (*P < 0.05 vs. pre-injection baseline, One-way 
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repeated measured ANOVA followed by Bonferroni t-test). Further, 
spontaneous pain was significantly reduced in TRPV1-/- mice in the first 15 min 
after injection, compared to the wild type mice  (##P < 0.001, #P < 0.05, vs. 
the wild type mice, Student’s t-test), but did not differ thereafter (Figure 1B and 
Figure 2A). When I examined mechanical sensitivity of hind paws in response 
to von Frey filaments following intrathecal DHPG injection, mechanical 
hypersensitivity was persistent throughout the 3.5 hr observation period in wild 
type mice, but was maintained for only 2 hr in TRPV1-/- mice (*P < 0.05 vs. 
pre-injection baseline, One-way repeated measure ANOVA followed by 
Bonferroni t-test) (Figure 2B). In addition, mechanical hypersensitivity in 
TRPV1-/- mice was lower than that of wild type mice (#P < 0.05 vs. wild type 
mice, Student’s t-test). Together, these results demonstrated that spinal TRPV1 
is associated with DHPG-induced pain behavior, such as spontaneous pain 
behaviors and mechanical allodynia. 
To determine the mechanisms underlying the interactions between group I 
mGluR receptors and TRPV1 in the spinal cord, I examined whether DHPG 
regulates TRPV1 activity in synaptic transmission of the spinal dorsal horn. I 
measured miniature excitatory postsynaptic current (mEPSC) of substantia 
gelatinosa (SG) neurons from spinal cord slice by using whole-cell patch clamp 
recording (Figure 3a). In this approach, DHPG had little effect on the amplitude 
of mEPSC (97.52 ± 0.93%, n = 4, P = 0.14 and 89.90 ± 4.04%, n = 3, P = 0.13) 
(Figure 3c and 3d); however, the frequency of mEPSC was significantly 
increased by DHPG (137.87 ± 2.10%, n = 4, P < 0.001 and 152.84 ± 1.19%, n = 
3, P < 0.001) (Figure 3c and 3d), and this was blocked by 5 μM capsazepine, a 
TRPV1 competitive antagonist (102.56 ± 2.08%, n = 4, P = 0.16) (Figure 3b 
and 3c) and 6-iodonordihydrocapsaicin, another structurally different TRPV1 
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antagonist (101.05 ± 2.07%, n = 3, P = 0.83) (Figure 3d). In addition, as shown 
previously (Tominaga et al., 1998; Hwang et al., 2004), EM analysis 
demonstrated that TRPV1 was clearly expressed on the perisynaptic region of 
the presynaptic terminals of sensory neurons in SG (Figure 4). Therefore, I felt 
it was reasonable to hypothesize that group I mGluRs and TRPV1 coupled on 
the presynaptic terminals of primary afferents neurons may regulate 
neurotransmitter releases, thereby contributing to DHPG-induced pain 
behaviors. 
 
Group I mGluRs drive DHPG-induced Ca2+ entry through TRPV1 channels 
in sensory neurons  
Next, I examined how DHPG modulates TRPV1 on presynaptic nociceptive 
neurons using fura-2 AM based ratiometric Ca2+ imaging. DHPG induced a 
Ca2+ response in subpopulations of DRG neurons, acutely isolated from 
neonatal rats. TRPV1-expressing nociceptive neurons were identified by their 
responsiveness to a 10 sec application of 200 nM capsaicin at the end of each 
experiment. In a subpopulation of capsaicin-sensitive neurons (35.74%, n = 
89/249), a 20 sec application of 100 μM DHPG induced a transient increase in 
[Ca2+]i that produced little desensitization during repetitive application of 
DHPG (93.90 ± 5.83%, n = 12, P = 0.31) (Figure 5Aa). DHPG-induced Ca2+ 
transients were abolished by pretreatment with 0 mM Ca2+ in the bath solution 
(2.44 ± 0.74%, n = 10, P < 0.05) (Figure 5Ab) but not by 1 μM thapsigargin 
(93.17 ± 10.61%, n = 15, P > 0.5) (Figure 5Ac), suggesting that DHPG-induced 
Ca2+ transients are mostly due to an influx of extracellular Ca2+ rather than Ca2+ 
release from intracellular Ca2+ stores. I next tested whether DHPG-induced Ca2+ 
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transients were associated with TRPV1. DHPG-induced Ca2+ transients were 
completely blocked by the pretreatment with 10 μM capsazepine (2.03 ± 0.18%, 
n = 14, P < 0.005) (Figure 5Ad), and 100 nM 5’-iodoresiniferatoxin (0.75 ± 
0.82%, n = 5, P < 0.005) (Figure 5Ae), which indicated that Ca2+ transients can 
indeed be attributed to Ca2+ influx mainly through TRPV1.  Further, Ca2+ 
transients were absent in TRPV1-/- mice (Figure 6).   
Given that TRPV1 is a non-selective cation channels with high permeability 
to both Ca2+ and Na+ (Clapham, 2003), I next examined whether DHPG induces 
TRPV1-mediated inward currents using whole-cell patch clamp recording. 
When capsaicin-sensitive DRG neurons were exposed to 100 μM DHPG for 10 
sec at a holding potential of -60 mV, inward currents were clearly evoked, 
which was readily reversible and blocked by 10 μM capsazepine (26.47 ± 
9.78%, n = 4, P < 0.05) (Figure 5Ba) and 100 nM 5’-iodoresiniferatoxin (12.77 
± 2.21%, n = 5, P < 0.001) (Figure 5Bb).   Further, the I-V relationship 
indicated that DHPG-induced currents have the characteristics of TRPV1-
mediated currents with a reversal potential of ~0 mV and a slight outward 
rectification (Figure 5Bd).  
 
mGluR5 drives DHPG-induced Ca2+ entry through TRPV1 channels in 
sensory neurons 
DHPG is a group I mGluRs agonist, and the two subtypes of group I 
mGluRs, mGluR1 and mGluR5, are both expressed in DRG neurons (Bhave et 
al., 2001). Thus, I determined the relative contribution of each subtype of 
mGluRs to DHPG-induced activation of TRPV1. In order to isolate only 
TRPV1-mediated Ca2+ responses produced by the application DHPG, I 
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eliminated the contribution of intracellular Ca2+ stores with 1 μM thapsigargin. 
Whereas CPCCOEt (50 μM), a mGluR1 specific antagonist, had a slight 
inhibitory effect (80.52 ± 3.80%, n = 13, P > 0.002) (Figure 7Aa), MPEP (50 
μM), a mGluR5 specific antagonist, clearly blocked DHPG-induced Ca2+ 
transients (9.15 ± 2.27%, n = 11, P < 0.001) (Figure 7Ab). Furthermore, CHPG, 
a mGluR5 specific agonist, induced Ca2+ transients that were similar to DHPG-
induced Ca2+ transients (74.93 ± 5.85%, n = 10, P > 0.002) (Figure 7Ac and 
7Ad). Single-cell RT-PCR analysis revealed that all of the DHPG-responsive 
cells expressed both mGluR5 and TRPV1, whereas mGluR1 expression was 
homogenous throughout the cells analyzed and was not correlated with the 
DHPG-induced Ca2+ transients in DRG neurons (Figure 7B). These results 
indicated that DHPG elicits Ca2+ influx via TRPV1, primarily through the 
activation of mGluR5 in capsaicin-sensitive nociceptors.  
 
DHPG-induced Ca2+ response results from direct activation of TRPV1 by 
DAG 
Next, I addressed the underlying mechanism for DHPG-induced activation 
of TRPV1. Since mGluR5 is G　q/11-coupled receptors linked to phospholipase 
C (PLC), and the activation of which results in the hydrolysis of PtdIns(4,5)P2 
to DAG and inositol-triphosphate (IP3) (Hermans and Challiss, 2001), I 
hypothesized that one of the signaling molecules in this pathway was involved 
in the TRPV1 activation by DHPG. While DHPG-induced Ca2+ transients were 
abolished by 2 μM U73122 (1.74 ± 0.13%, n = 12, P < 0.001), a specific PLC 
inhibitor (the inactive form of 2 μM U73343 had no effect) (Figure 8Aa), 
DHPG-induced Ca2+ transients persisted in the presence of 1 μM staurosporine 
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(89.10 ± 4.20%, n = 9, P > 0.01), a non-specific protein kinase inhibitor (Ruegg 
and Burgess, 1989) or 1 μM bisindolylmaleimide (BIM) (83.50 ± 2.98%, n = 9, 
P > 0.001), a specific PKC inhibitor, and with 1 μM RHC80267, a DAG lipase 
inhibitor (Figure 8Ab). These results indicated that downstream signaling 
molecules of PLC mediated DHPG-induced Ca2+ transients and that these 
effects were a result of a protein kinase- and DAG lipase-independent activation 
of TRPV1, implying that DAG as the most plausible candidate molecule. 
Indeed, I have recently shown that 1-oleoyl-2-acetyl-sn-glycerol (OAG), a 
membrane-permeable analogue of DAG, directly activates TRPV1 (Woo et al., 
2008). I further found in the present study that bath application of OAG 
produced a Ca2+ transient that was blocked by capsazepine (2.68 ± 0.73%, n = 
12, P < 0.001), but not by staurosporine and RHC80267 (80.85 ± 3.32%, n = 12, 
P > 0.001) in DRG neurons (Figure 8Ac and 8Ad). I also examined whether 
OAG could induce inward currents via TRPV1 in DRG neurons. In capsaicin-
responsive DRG neurons, 100 μM OAG evoked inward currents (0.20 ± 0.05 
nA, n = 6) that were completely blocked by 10 μM capsazepine (Figure 8Ba). 
Further, the I-V relationship exhibited a typical non-selective cationic current of 
the TRPV1 response with a reversal potential of ~0 mV and a slight outward 
rectification (Figure 8Bb). In addition, when I performed cell-attached patch 
clamp recordings, single channel activities were elicited by 100 μM DHPG, 
only when applied through the pipette solution, but not when applied through 
the bath solution. 1 μM capsaicin, applied either through the pipette or the bath 
solution, elicited higher single channel activities, compared to 100 μM DHPG 
(Figure 9). These results suggest that the effect of DHPG on TRPV1 is 
mediated by a membrane-delimited pathway, but not by a diffusible molecule. 
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DAG directly activates the TRPV1 channel in a membrane-delimited manner 
I have also demonstrated the mechanisms by which DAG activates TRPV1 
using whole-cell patch clamp recording in a heterologous expression system 
(Woo et al., 2008). To provide further evidences on the membrane-delimited 
activation of TRPV1, I used Ca2+ imaging in the present study. As indicated in 
the previous study (Woo et al., 2008), one possible mechanism of this pathway 
would be direct interaction between DAG and TRPV1. To investigate this 
possibility, I used Y511A mutants of TRPV1 (Jordt and Julius, 2002) transiently 
expressed in HEK293 cells. This mutant failed to respond to OAG as well as 
capsaicin (n = 10) (Figure 10A), suggesting that capsaicin and OAG share the 
Y511 binding site for activation of TRPV1. Alternatively, DAG might produce 
its effects by replacing PtdIns(4,5)P2 from an inhibitory site on TRPV1 
(Prescott and Julius, 2003). Thus, I also examined whether DAG activates 
TRPV1 in ∆774-838 mutants of TRPV1, which lack a PtdIns(4,5)P2 binding site 
(786-828) (Ferrer-Montiel et al., 2004). OAG-induced Ca2+ transients remained 
in ∆774-838 mutant, which suggested that this site might not be critical for the 
activation of TRPV1 by DAG. Normal response to acid stimulus (pH 5.5) of 
naïve TRPV1, Y551A and ∆774-838 mutants of TRPV1 was used to 
demonstrate normal functional expression of these constructs in my 
experimental system (Figure 10B).  
I further verified the modulation of TRPV1 by mGluR5 activation in 
HEK293 cells. To isolate only TRPV1-mediated responses, I examined DHPG-
induced Ca2+ transients again in the presence of 1 μM thapsigargin. I found that 
mGluR5 behaved differently depending on the co-expression of TRPV1. DHPG 
failed to elicit any Ca2+ response in either mGluR5-expressing or TRPV1-
expressing HEK293 cells. In contrast, DHPG elicited Ca2+ response (1.75 ± 
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0.08 ratio, n = 10) that was abolished by capsazepine (0.16 ± 0.01 ratio, n = 10, 
P < 0.01) in HEK293 cells transiently transfected with both mGluR5 and 
TRPV1 (Figure 11a and 11b). Similar response patterns were observed with 100 
μM glutamate as a mGluR5 agonist (Figure 12). These results clearly 
demonstrated that TRPV1 is trans-activated by mGluR5 to induce Ca2+ influx 
rather than Ca2+ mobilization from intracellular Ca2+ stores. I also confirmed 
normal functioning of mGluR5 by evaluating Ca2+ mobilization from 
intracellular stores, observing either Ca2+ oscillation or Ca2+ transients produced 




Figure 1. Intrathecal administration of DHPG induces 
spontaneous pain  
A, Spontaneous pain behavior (n = 5) (a) and mechanical sensitivity of 
hindpaws (n = 5) (b) were not affected by vehicle injection. Also, there was no 
discernible difference between in TRPV1 knock-out (open circle) and wild-type 
(closed circle) mice. B, Spontaneous pain behaviors induced by intrathecal 
administration of DHPG (15 nmol, 5 μl) in TRPV1 knock-out (open circle) and 
wild type (closed circle) mice. *P < 0.05 vs. pre-injection baseline (One-way 






Figure 2. Activation of spinal mGluR5 induces pain 
behavior 
  
Effects of DHPG (15 nmol, 5 μl, i.t.) on spontaneous pain behavior (n = 5, each 
group) (A) and mechanical sensitivity to von Frey filaments (n = 6-8; each 
group) (B) in both TRPV1 knock-out (open circle) and wild type (closed circle) 
mice. **P < 0.001, *P < 0.05 vs. pre-injection baseline (One-way repeated 
measure ANOVA followed by Bonferroni t-test); ##P < 0.001, #P < 0.05 vs. 




























Figure 3. mGluR5 and TRPV1 are coupled on central 
presynaptic terminals 
 
a, Effects of DHPG on glutamatergic mEPSCs in spinal SG neurons. Traces 
from a cell before (left) and during 100 μM DHPG (middle, 1 min after the 
onset of DHPG application), and during 5 μM CZP with 100 μM DHPG (right, 
5 min pre-treatment of CZP and 1 min after the onset of DHPG application). 
CZP indicates capsazepine. b, Normalized cumulative probability distributions 
of the amplitude and the inter-event intervals of mEPSCs. c and d, Bar graphs 
illustrate the percentage change in mean amplitude and frequency of mEPSCs. 
6-iodo-CAP: 6-iodonordihydrocapsaicin. (*P < 0.001, paired t-test versus 
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Figure 5. DHPG induces Ca2+ transients through 
TRPV1 in nociceptive sensory neurons 
 
A, Ca2+-transients evoked by sequential application of 100 μM DHPG (n = 12) 
(a) were blocked by extracelluar Ca2+-free condition (n = 10) (b) but not by 1 
μM thapsigargin (n = 15) (c). DHPG-induced Ca2+-transients were also 
abolished by 10 μM CZP (n = 14) (d) and 100 nM 5’-iodoresiniferatoxin (IRTX, 
n = 5) (e). CAP indicates capsaicin. Summary of Ca2+ response relative to peak 
amplitude of 1st DHPG response (*P < 0.05, paired t-test versus 1st DHPG 
response). Results are presented as the mean ± SEM (f). B, (a) Representative 
DHPG-induced current traces from CAP-sensitive DRG neurons at a holding 
potential of -60 mV. DRG neurons were repetitively exposed to 100 μM DHPG 
at 10 min intervals. DHPG-induced currents were abolished by 10 μM CZP (n = 
4) (a) and 100 nM IRTX (n = 5) (b). (c) Summary of the current responses as 
measured by peak amplitude current, relative to peak amplitude of 1st DHPG 
response (*P < 0.05, paired t-test versus 1st DHPG response). Results are 
presented as the mean ± SEM. (d) I-V relationship obtained by a voltage ramp 
protocol from -100 to +60 mV during DHPG induced current (gray) and before 






Figure 6. DHPG induced Ca2+ transients are absent in 
TRPV1-/- mice  
 
DHPG-induced Ca2+ responses were compared between TRPV1 wild-type and 
TRPV1-/- mice. Sequential application of 100 μM DHPG elicited Ca2+ transients 
that were abolished by 100 nM IRTX in TRPV1 wild-type mice (2.33 ± 2.25%, 
n = 15, *P < 0.05). However, 100 μM DHPG either failed to elicit Ca2+ 
transients (n = 15) or just produced Ca2+ oscillation in TRPV1-/- mice (n = 3). 





















Figure 7. mGluR5 mediates DHPG-induced Ca2+ 
transients in nociceptive sensory neurons 
 
A, DHPG-induced Ca2+ transients were not abolished by the mGluR1 specific 
antagonist, 50 μM CPCCOEt (n = 13) (a), but were abolished by the mGluR5 
specific antagonist, 50 μM MPEP (n = 11) (b). [Ca2+]i transients were also 
induced by the mGluR5 specific agonist, 300 μM CHPG (n = 10) (c). Summary 
of Ca2+ responses relative to the 1st DHPG response (*P < 0.001, paired t-test 
versus 1st DHPG response). Results are presented as the mean ± SEM (d). B, 
Whole tissue RT-PCR analysis indicated expression of mGluR1 (145 bp), 
mGluR5 (202 bp) and TRPV1 (330 bp) in DRG neurons. Combination of 
single-cell RT-PCR following Ca2+ imaging (n = 20) revealed an association 
between coexpression of mGluR5 and TRPV1, and the responsiveness to 
DHPG and CAP. DRG neurons responsive to both DHPG and capsaicin 
expressed mGluR1, mGluR5 and TRPV1 (1, n = 8/8), whereas DRG neurons 
responsive to only capsaicin, but not DHPG, expressed mGluR1 and TRPV1 (2, 
n = 8/8). DRG neurons unresponsive to DHPG only expressed mGluR1 (3, n = 
4/4). The control obtained in bath solution without harvesting cells was 
negative for all of the tested primers. The three images represent Fura-2 ratio 
images taken before and during DHPG and CAP applications. Numbers indicate 
each cell shown in single-cell RT-PCR results. Traces show Ca2+ transients in 










Figure 8. DHPG-induced Ca2+ response results from 
direct activation of TRPV1 produced by DAG 
 
A, DHPG induced Ca2+-responses were abolished by 2 μM U73122 (n = 12), 
but not by 2 μM U73343 (n = 12) (a). Treatment with either 1 μM staurosporine 
(SP) or 1 μM bisindolylmaleimide (BIM) with 1 μM RHC80267 (n = 9 each) 
had no effect on [Ca2+]i transients by DHPG (b). [Ca2+]i transients evoked by 
100 μM OAG were not affected by 1 μM SP and 1 μM RHC80267 (n = 12), but 
were abolished by pre-treatment with 10 μM CZP (n = 12) (c). Summary of 
Ca2+ responses relative to the 1st DHPG or OAG response (*P < 0.001, paired t-
test versus 1st DHPG or OAG response). Results are mean ± SEM (d). B, (a) 
Representative current traces from CAP-sensitive DRG neurons at a holding 
potential of -60 mV. DRG neurons were exposed to 100 μM OAG twice at 10 
min interval (n = 6). OAG-induced currents were abolished by CZP (n = 6). (b) 
I-V relationship obtained by a voltage ramp protocol from -100 to +60 mV 
during OAG induced current (2) and before OAG application (1) exhibited a 












Figure 9. DHPG induced single channel conductance of 
TRPV1 is mediated by a membrane-delimited pathway 
 
Cell-attached patch clamp recordings at a command potential of +40 mV in 
DRG neurons. A, In the absence of DHPG and capsaicin (CAP), no single 
channel activities were observed in the experimental condition (a) (n = 12 / 12). 
Single channel activities were not recorded by bath application of 100 μM 
DHPG (b) (n = 5 / 5), but by bath application of 1 μM CAP (c) (n = 5 / 7). B, 
Single channel activities were elicited by 100 μM DHPG when applied through 
the pipette solution (a) (n = 6 / 16), and higher single channel activities were 
observed with sequential bath application of 1 μM CAP in the same DRG 
neurons (b) (n = 6 / 6). C, 1 μM CAP included in the pipette solution highly 
activated single channel currents in DRG neurons (n = 4 / 6). D, All-points 
histogram for channel activities by intra-pipette application of 100 μM DHPG 
(1.44 ± 0.01 pA, Po = 0.23) (a) and by extracellular application of 1 μM CAP 
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Figure 12. Glutamate induces trans-activation of 
TRPV1 in mGluR5 / TRPV1-expressing HEK 293 cells 
Application of 100 μM glutamate (20 s) induced increments of [Ca2+]i in 
mGluR5-expressing HEK 293 cells. These responses were abolished by 
pretreatment of thapsigargin (5 min), indicating that glutamate-induced Ca2+ 
response in mGuR5-expressing HEK 293 cells was due to a release from 
intracellular Ca2+ stores. However, in mGuR5 and TRPV1-expressing HEK 293 
cells, glutamate-induced Ca2+ responses were not completely blocked by 
pretreatment with thapsigargin. The glutamate-induced Ca2+ responses in the 
presence of thapsigargin were blocked by 25 μM 6-iodonordihydrocapsaicin (6-
iodo-CAP), a TRPV1 antagonist. Also, TRPV1-expressing HEK 293 cells were 
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I revealed that TRPV1 and mGluR5 are linked in a membrane-delimited 
manner on the central presynaptic terminals of nociceptive neurons, together 
serving as presynaptic modulators of nociceptive transmission in the spinal SG 
area. Spinal TRPV1 is involved in pain behaviors produced by the onset of 
activation of spinal group I mGluR activation. Given that the enhancement of 
mEPSC frequency, but not of the amplitude, induced by DHPG was 
significantly reduced by TRPV1 antagonism, it was believed that coupling of 
TRPV1 and group I mGluRs on presynaptic terminals could contribute to 
DHPG-induced pain responses. The in vitro results further demonstrated that 
mGluR5, rather than mGluR1, is coupled to TRPV1, and that DAG produced 
by the activation of mGluR5 is responsible for mediating the functional 
coupling of mGluR5 and TRPV1 on presynaptic terminals. Based on my 
observations, it was thought that cellular mechanisms of spinal presynaptic 
mGluR5 might be distinct from those of both peripheral mGluR5 and spinal 
postsynaptic mGluR5. In addition to TRPV1’s well-known action as a 
transducer for pain sensation on the peripheral sensory terminals, it is also 
highly likely that presynaptic TRPV1, coupled with mGluR5, acts as a Ca2+ 
regulator for synaptic transmission in the SG area.  
I found that the effects of mGluR5 activation observed in the calcium 
imaging and electrophysiology experiments were mediated by TRPV1. Since 
capsazepine, at micromolar concentrations, is known to produce inhibitory 
effects on voltage-gated calcium currents (Docherty et al., 1997) in addition to 
its well-known TRPV1 antagonistic effect, I verified TRPV1-dependent actions 
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following mGluR5 activation by additionally using structurally different 
TRPV1 antagonists such as 5’-iodoresiniferatoxin and 6-
iodonordihydrocapsaicin. Notably, I also found that the effect of 5-10 μM 
capsazepine per se on mEPSCs was negligible, suggesting the limited effects of 
capsazepine on voltage-gated calcium currents under my experimental 
conditions. Absence of Ca2+ transients in response to mGluR5 activation in 
TRPV1-/- mice further revealed TRPV1-specific effects of mGluR5 activation.  
 Given that the DHPG response was not blocked by the combination of a 
non-specific protein kinase inhibitor/or PKC inhibitor and DAG lipase inhibitor, 
DAG produced a response comparable to DHPG, DHPG, only applied into the 
pipette but not to the bath solution, generated single channel activity, and DAG-
induced Ca2+ transients were not observed in the capsaicin-binding site TRPV1 
mutant, it seems clear that TRPV1 activation by mGluR5 activation occurs via a 
membrane-delimited generation of DAG. The generation of DAG may be 
associated with the cellular mechanism for synaptic transmission of nociceptive 
information in the SG area in the spinal dorsal horn. Although lipid metabolite 
products such as HPETE and anandamide have been suggested as candidate 
molecules for mediating GPCR-activation of TRPV1 (Hwang et al., 2000; van 
der Stelt et al., 2005), the identity of endogenous ligands for TRPV1 at the 
pathophysiological conditions, especially in the central neurons, are still 
debated. Recent study demonstrated that DAG is a novel endogenous ligand of 
TRPV1 (Woo et al., 2008). In the present study, I provide further strong 
evidence that group l mGluR5 activates the TRPV1 channel in a membrane-
delimited manner and DAG mediates functional coupling of group l mGluR5 
and TRPV1 on central presynaptic terminals of sensory neurons.  
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Mechanisms for direct induction of TRPV1 activity by mGluR5 activation in 
the central presynaptic terminals, which are investigated in this study, seem to 
be different from those of the enhancement of peripheral TRPV1 function by 
mGluR5 activation. A previous study demonstrated that activation of mGluR5 
on peripheral sensory terminals sensitizes and enhances TRPV1 via PKA and 
cyclooxygenase pathways (Huang et al., 2002). It is difficult at this point to link 
these two distinctive in vitro results with the appropriate behavioral experiments. 
However, my experimental finding may reflect differential functional roles of 
peripheral mGluR5 and central presynaptic mGluR5 in nociceptive signaling. 
While glutamate, as a key inflammatory mediator released in the periphery after 
inflammation, acts on mGluR5 for a relatively long period (deGroot et al., 
2000), glutamate released from presynaptic terminals may act rapidly on 
mGluR5 due to the recycling of glutamate to astrocytes via glutamate 
transporters (Oliet et al., 2001). Therefore, I thought that application of DHPG 
for short periods of time (20 sec for Ca2+ imaging, 10 sec for electrophysiology) 
rather than 3 min as in a previous study (Huang et al., 2002) would be more 
appropriate for elucidating the mechanisms of spinal presynaptic mGluR5. 
Application of DHPG for long periods could mask the effects of membrane-
delimited activation of TRPV1 by mGluR5 activation.  
Additionally, as previously suggested (Delmas et al., 2002), it is possible 
that the spatial proximity of receptors (i.e. mGluR5) and target channels (i.e. 
TRPV1) may determine the specificity of Ca2+ responses produced by G　q/11-
coupled receptors which could recruit then either membrane-delimited 
pathways or downstream pathways inside the cytosol. It remains to be 
elucidated whether geometrical distances between mGluR5 and TRPV1 are 
different on peripheral and central nociceptive terminals, and how preferential 
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functional couplings between different GPCRs and TRP channels are 
determined at the molecular level.   
Group I mGluRs, namely mGluR1 and mGluR5, are distributed on 
peripheral unmyelinated sensory afferents, in both DRG neurons (Bhave et al., 
2001) and spinal dorsal horn (Alvarez et al., 2000). These receptors function 
such that the activation of peripheral and spinal mGluR1/mGluR5 is sufficient 
to evoke pain hypersensitivity (Lesage, 2004). However, mGluR1 and mGluR5 
may have different cellular mechanisms for their nociceptive signaling. Recent 
reports demonstrate that mGluR5 is the predominant group I mGluR mediating 
DHPG-induced responses both in cultured mouse DRG neurons (Huang et al., 
2002) and in spinal dorsal horn neurons (Hu et al., 2007). The results also 
demonstrate that mGluR5 is highly likely to be the predominant group I mGluR 
on the central presynaptic terminals. Immunohistochemical analysis also 
revealed double-labeling of DRG neurons with mGluR5 and TRPV1 (Figure 
13), which is consistent with the results of a previous report (Walker et al., 
2001a).   
SG neurons are the first central neurons to relay input from primary afferent 
neurons (Sugiura et al., 1986). Thus, synaptic modulation of primary afferent 
neurons in the SG is believed to play an important role not only in acute 
nociceptive transmission, but also in central sensitization associated with 
chronic pain (Lu and Perl, 2005). Recently, it has been demonstrated that 
mGluR5 modulates nociceptive plasticity via Kv4.2 signaling in postsynaptic 
spinal dorsal horn neurons (Hu et al., 2007). My results suggest that mGluR5 on 
the central presynaptic terminals of nociceptive neurons may also play an 
important role for the central sensitization under pathological pain conditions 
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by membrane-delimited coupling with TRPV1. While presynaptic mGluR5 
might be silent in normal physiological pain transmission, mGluR5 present in 
the perisynaptic area (Jia et al., 1999; Pitcher et al., 2007) could be activated by 
glutamate spilled over the synaptic cleft following excessive release from 
central terminals of nociceptive neurons under pathological conditions such as 
peripheral inflammation and nerve injury. The subsequent Ca2+ influx via 
TRPV1 induced by mGluR5 activation may lead to further glutamate release 
from central terminals, thereby providing a positive feedback cycle via 
autocrine function. It has been reported that activation of spinal TRPV1 induced 
release of substance P (Marvizon et al., 2003) which is necessary for central 
sensitization of dorsal horn neurons (Ikeda et al., 2003). This observation may 
be associated with the induction of DHPG-induced pain hypersensitivity 
documented in the behavioral study. 
The present results suggest a plausible cellular mechanism for the 
contribution of central presynaptic mGluR5 and TRPV1 to nociceptive 
transmission in the spinal cord. The direct activation of TRPV1 and strong Ca2+ 
signaling induced by DAG following mGluR5 activation implies a previously 
unknown significant role for TRPV1 as an integrator of multiple G　q/11-coupled 





CHAPTER 2:             
TRPV1 in GABAergic Interneurons 
Mediates Neuropathic Mechanical 
Allodynia and Disinhibition of the 







Neuropathic pain and allodynia may arise from sensitization of central 
circuits.  I report a novel mechanism of disinhibition-based central 
sensitization resulting from long-term depression (LTD) of GABAergic 
interneurons as a consequence of TRPV1 activation in the spinal cord. 
Intrathecal administration of TRPV1 agonists led to mechanical allodynia that 
was not dependent on peripheral TRPV1 neurons. TRPV1 was functionally 
expressed in GABAergic spinal interneurons and activation of spinal TRPV1 
resulted in LTD of excitatory inputs and a reduction of inhibitory signaling to 
spinothalamic tract (STT) projection neurons. Mechanical hypersensitivity after 
peripheral nerve injury was attenuated in TRPV1-/- mice but not in mice lacking 
TRPV1-expressing peripheral neurons. Mechanical pain was reversed by a 
spinally applied TRPV1 antagonist while avoiding the hyperthermic side effect 
of systemic treatment.These results demonstrate that spinal TRPV1 plays a 
critical role as a synaptic regulator and suggest the utility of CNS-specific 





Pain hypersensitivity generated by peripheral injury can result from plastic 
changes in both the peripheral (Campbell and Meyer, 2006; Finnerup et al., 
2007) and central nervous systems (Coull et al., 2003; Ikeda et al., 2003; 
Costigan et al., 2009). Mechanical allodynia, pain response to light touch, is the 
most common and challenging symptom found in pathological pain (Campbell 
and Meyer, 2006). The mechanisms underlying induction and maintenance of 
mechanical hypersensitivity are still uncertain (Costigan et al., 2009) but the 
dominant population of Nav1.8-expressing peripheral neurons that mediate 
acute mechanical and thermal pain are not required (Abrahamsen et al., 2008). 
The transmission of pain signals from primary afferent neurons to higher brain 
centers is controlled by a balance between excitatory and inhibitory signaling in 
the spinal cord dorsal horn (Kuner, 2010). A key area for pain processing is the 
substantia gelatinosa (SG) of the spinal dorsal horn and inhibitory SG 
interneurons have been proposed as a gate of pain transmission and other 
sensory modalities to higher brain centers (Melzack and Wall, 1965). It has 
been suggested that a reduction in tonic and phasic inhibitory control or 
‘disinhibition’ in the spinal dorsal horn is responsible for the amplification of 
pain messages that produces hyperalgesia and allodynia (Yaksh, 1989; Sivilotti 
and Woolf, 1994) following peripheral nerve injury (Moore et al., 2002; 
Basbaum et al., 2009). Thus, central rather than peripheral mechanisms appear 
to be responsible for the hyperexcitability of nociceptive signaling leading to 
neuropathic mechanical allodynia (Woolf et al., 1992; Coull et al., 2003; 
Torsney and MacDermott, 2006; Costigan et al., 2009). 
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TRPV1 antagonists have shown efficacy in animal models of both 
inflammatory and neuropathic pain (Patapoutian et al., 2009) but systemic 
administration of TRPV1 antagonists commonly results in hyperthermia caused 
by peripheral TRPV1 blockade (Steiner et al., 2007). Activation of spinal 
TRPV1 can generate central sensitization and mechanical allodynia 
(Patwardhan et al., 2009) and spinal administration of TRPV1 antagonists can 
attenuate mechanical allodynia induced by nerve injury (Patapoutian et al., 
2009) but the cell types or circuits underlying these effects are unknown. 
Mechanical allodynia associated with TRPV1 activation is unlikely to depend 
on TRPV1-expressing primary sensory neurons as these are not necessary for 
the transduction of painful mechanical stimuli (Cavanaugh et al., 2009) and a 
mechanical pain phenotype is not observed in TRPV1-/- mice (Caterina et al., 
2000). Thus the mechanism of action for TRPV1 antagonism in neuropathic 
mechanical pain relief remains unknown. The expression of TRPV1 in spinal 
cord SG neurons has recently been suggested (Ferrini et al., 2010). Therefore, I 
speculated that central TRPV1 may be involved in neuropathic mechanical pain. 
Here I explored the role of spinal TRPV1 in the spinal cord nociceptive 
circuitry and further investigated its contribution to the enhancement of 




MATERIALS AND METHODS 
 
All surgical and experimental procedures were reviewed and approved by 
the Institutional Animal Care and Use Committee (IACUC) at the School of 
Dentistry, Seoul National University. Animal treatments were performed 
according to the guidelines of the International Association for the Study of 
Pain (Zimmermann, 1983). Adult C57BL/6J (wild type) male mice were 
purchased from Orientbio (Korea) and heterozygous C57BL/6J BAC transgenic 
male mice expressing EGFP under the control of the GAD65 promoter 
(GAD65-EGFP mice) (Lopez-Bendito et al., 2004), provided by the Korea 
Institute of Science and Technology. Animals were housed in a conventional 
facility with a 12:12 hr light cycle (lights on 8.00am) and ad libitum access to 




For mechanical threshold (von Frey filament) testing, mice were brought 
from the animal colony and placed in transparent plastic boxes (60 × 100 × 60 
mm) on a metal mesh floor (3 × 3 mm mesh). The mice were then left alone for 
at least 20 min to allow them to acclimate prior to testing. To assess mechanical 
sensitivities, the withdrawal threshold of the hindpaw was measured using a 
series of von Frey filaments (0.20, 0.69, 1.57, 3.92, 5.88, 9.80, 19.60 and 39.20 
mN, Stoelting, Wood Dale, IL, USA; equivalent in grams to 0.02, 0.07, 0.16, 
0.40, 0.60, 1.0, 2.0 and 4.0). The 50% withdrawal threshold was determined 
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using the up-down method as previously described (Chaplan et al., 1994). A 
brisk hindpaw lift in response to von Frey filament stimulation was regarded as 
a withdrawal response. The 0.4 g filament was the first stimulus to be used, and, 
when a withdrawal response was obtained, the next weaker filament was used. 
This process was repeated until no response was obtained, at which time the 
next stronger filament was administered. Interpolation of the 50% threshold 
was then carried out using the method of Dixon (Dixon, 1980). All behavioral 
testing was performed by an investigator who was blind to the genetic 
background of the mice. 
 
Intrathecal injection 
Capsaicin (1 μg) and BCTC (10 μg) were dissolved in 0.9% saline using an 
ultrasonic washer and applied intrathecally. Intrathecal administration was 
performed as described previously (Hylden and Wilcox, 1980). Briefly, under 
light enflurane anesthesia (2% in 100% O2), the vertebral column of mouse was 
held using the thumb and middle finger of the left hand and the drug was 
injected intrathecally into each mouse using a 25 μl Hamilton syringe fitted 
with 31 gauge needle at approximately the lumbar enlargement level of the 
spinal cord. The injection volume was 5 μl and the injection sites were verified 
by injecting a similar volume of 1% methylene blue solution and determining 
the distribution of the injected dye in the spinal cord. Before conducting 
experiments, the injection method was practiced until the success rate was 
consistently over 95%.  
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RTX ablation of peripheral TRPV1-expressing neurons 
3 – 4 week old mice were intraperitoneally injected with RTX or vehicle 
(dissolved in a mixture of 10% Tween 80 and 10% ethanol in normal saline) 
under isoflurane anesthesia (2% in oxygen) as a single bolus in two injections 
of 50 μg/kg and 150 μg/kg on days 1 and 2, consecutively. The mice were 
maintained under isoflurane anesthesia (0.5% in oxygen) for 2 – 3 hour 
following RTX or vehicle injection. The RTX-treated mice were used in 
experiments at least 7 days after final RTX injection. Successful depletion of 
TRPV1-afferent nerves was confirmed by application of a 0.01 mM capsaicin 
solution to the eye; vehicle-injected mice responded to capsaicin application 
with 1-2 min vigorous eye wiping, but RTX-injected mice did not. TRPV1 
immunoreactivity was reduced in the DRG (Figure 2B) and spinal dorsal horn 
of RTX-treated mice to levels comparable to TRPV1-/- mice (Figure 2A), 
reflecting a loss of peripheral and presynaptic receptors, respectively. RTX-
treatment also led to a loss of capsaicin-induced sEPSCs in SG neurons (Figure 
2C). I further confirmed the efficacy of RTX to functionally eliminate TRPV1 
receptors by calcium imaging of isolated DRG neurons. Approximately 63% of 
DRG neurons from Wt mice but less than 2% of DRG neurons from RTX-
treated mice showed a response to capsaicin (Figure 2D). 
 
Real-time RT-PCR 
Real-time PCR was performed using a 7500 Real-Time PCR system 
(Applied Biosystems). Relative mRNA levels were calculated according to the 
2-ΔΔCt method (Livak and Schmittgen, 2001). All ΔCt values were normalized 
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to GAPDH. Real-time RT-PCR experiments were performed at least three times, 
and the mean ± SEM values are presented unless otherwise noted. The PCR 
primer sequences used in this study are listed in Table A. 
 
DRG preparation 
DRG neurons obtained from 4 –6-week old mice were prepared. Animals 
were anesthetized with overdose of isoflurane, decapitated, and DRGs were 
rapidly removed under aseptic conditions and placed in HBSS (Gibco). DRGs 
were digested in 1 mg/ml collagenase A (Roche) and 2.4 U/ml dispase II 
(Roche) in HBSS for 60 min, respectively, followed by 8 min in 0.25% trypsin 
(Sigma), all at 37°C. The DRGs were then washed in DMEM (Gibco) three 
times and resuspended in DMEM medium supplemented with 10% FBS 
(Invitrogen) and 1% penicillin/streptomycin (Sigma). DRGs were then 
mechanically dissociated using fire-polished glass pipettes, centrifuged (800 
rpm, 5 min), resuspended in DMEM medium supplemented with 5% FBS 
(Invitrogen), 20 ng/ml NGF (Invitrogen), 1× N-2 supplement (Invitrogen), and 
1% penicillin/streptomycin (Invitrogen), and plated on 0.5 mg/ml poly-l-
ornithine (Sigma)-coated glass coverslips. Cells were maintained at 37°C in a 5% 
CO2 incubator.  
Forward primer
Mouse GAPDH




Target gene Reverse primers                   Genbank No.




I performed fura-2 AM-based (Molecular Probes) Ca2+ imaging experiments 
as previously described (Kim et al., 2009a). Briefly, DRG neurons prepared 
were loaded with fura-2 AM (2 μM) for 40 min at 37°C in a balanced salt 
solution [BSS; containing (in mm) 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 N-
[2-hydroxyethyl]piperazine-N′-[2-ethanesulfonic acid] (HEPES), 10 glucose, 
adjusted to pH 7.3 with NaOH]. The cells were then rinsed with DMEM and 
incubated in DMEM for an additional 20 min to de-esterify the dye. Cells on 
slides were placed onto an inverted microscope and illuminated with a 175 W 
xenon arc lamp; excitation wavelengths (340/380 nm) were selected by a 
monochromator wavelength changer. Intracellular calcium concentrations 
([Ca2+]i) were measured by digital video microfluorometry with an intensified 
charge-coupled-device camera (CasCade, Roper Scientific) coupled to the 
microscope and a computer with Metafluor software (Universal Imaging). All 
drugs were applied via bath perfusion at a flow rate of 5 ml/min. 
 
Electron microscopy 
C57BL6 mice (male, 6 week-old) were deeply anesthetized with sodium 
pentobarbital (80 mg/kg, i.p.) and perfused transcardially with 4% 
paraformaldehyde in 0.1 M phosphate buffer, (PB; pH 7.4). The brainstem and 
L4 DRG were removed and cut transversely on a vibratome at 60 μm. The 
sections were post-fixed in the mixture of 4% paraformaldehyde and 0.01% 
glutaraldehyde in 0.1 M PB for 30 min at 4 °C and then cryoprotected in 30 % 
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sucrose in PB overnight at 4 °C. Sections were frozen on dry ice for 20 min and 
thawed in phosphate buffered saline (PBS; 0.01M, pH 7.2) to enhance 
penetration of antibody, blocked with 3% H2O2 for 10 min to suppress 
endogenous peroxidases, and with 10% normal donkey serum (NDS; Jackson 
Immunoresearch, West Grove, PA, USA) for 30 min to mask secondary 
antibody binding sites. For double immunostaining for TRPV1 and GAD, 
sections of L4 DRG pretreated as above were incubated overnight in a mixture 
of goat anti-TRPV1 (1:500; Santa Cruz Biotechnology, Santa Cruz, CA) and 
mouse anti-glutamic acid decarboxylase 65/67 (GAD65/67, a marker for 
GABAergic neurons; dilution 1:1,000; Stressgen Biotechnologies) antibodies. 
After rinsing in PBS, sections were incubated with a mixture of biotinylated 
donkey anti-goat (1:200, Jackson Immunoresearch) and gold-conjugated 
donkey anti-mouse (1:50; EMS, Hatfield, PA, USA) antibodies for 2 hour. The 
sections were post-fixed with 2% glutaraldehyde in PB for 10 min, rinsed in 
PBS several times and incubated for 4 min in silver intensification solution (HQ 
silverTM Enhancement Kit, Nanoprobes, USA) and rinsed in 0.1 M sodium 
acetate and PB. The sections were then incubated with ExtrAvidin peroxidase 
(1:5,000; Sigma, St. Louis, MO, USA) for 1 hour, and the immunoperoxidase 
was visualized by nickel-intensified 3.3'-diaminobenzidine tetrahydrochloride 
(DAB). Sections were further rinsed in PB, osmicated (0.5% osmium tetroxide 
in PB) for 1 hour, dehydrated in graded alcohols, flat embedded in Durcupan 
ACM (Fluka, Buchs, Switzwerland) between strips of Aclar plastic film (EMS), 
and cured for 48 hour at 60 °C. The sections were cut with diamond knife, 
collected on formvar coated single slot nickel grids and stained with uranyl 
acetate and lead citrate. Grids were examined on a Hitachi H-7500 electron 
microscope (Hitachi, Tokyo, Japan) at 80 kV accelerating voltage. Images were 
71 
captured with a DigitalMicrograph software driving a cooled CCD camera 
(SC1000; Gatan, Pleasanton, CA, USA) attached to the microscope, and saved 
as TIFF files. 
 
DRG immunohistochemistry 
Naïve (n=3) and RTX-treated C57BL/6 mice (n=3) were deeply 
anaesthetized with sodium pentobarbital (100 mg/kg i.p.) and perfused 
transcardially with heparinised saline (500 U/l) followed by Zamboni fixative 
(4% paraformaldehyde, 2% picric acid, pH 7.4). Bilateral L4 and L5 DRG were 
removed and cryoprotected in a 30% sucrose PBS solution overnight. DRG 
from mice of both groups were frozen embedded together and cryosections (14 
µm) were cut and thaw mounted to Superfrost slides. After blocking for one 
hour at room temperature (5% normal donkey serum, 0.1% triton-X 100) 
sections were probed with guinea pig anti-TRPV1 (1:1000) (Chemicon) 
overnight at 4°C followed by FITC–conjugated donkey anti-guinea pig (1:200) 
(Jackson) for 1 hour at room temperature in PBS (pH 7.6). Images were 
captured with a confocal microscope (Olympus FV-300, Japan) with identical 
acquisition parameters. 
 
Slice preparation of mouse spinal cord 
I used adult (4 - 6-week old) C57BL/6J (wild type) male mice and 
heterozygous C57BL/6J BAC transgenic male mice expressing EGFP under the 
control of the GAD65 promoter (GAD65-GFP mice) (Lopez-Bendito et al., 
2004). Mice were deeply anesthetized with excess isoflurane, and the spinal 
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cord including lumbosacral enlargement was exposed by a dorsal laminectomy. 
Dissected tissue blocks were placed into ice-cold cutting solution containing (in 
mM): 245 sucrose; 3 KCl; 6.0 MgCl2; 0.5 CaCl2; 26 NaHCO3; 1.25 NaH2PO4; 
11 glucose; 5 HEPES; 1.0 Kynurenic acid (pH 7.4, when bubbled with 95% O2 
/ 5% CO2). Transverse slices (300 μm) were prepared using vibroslicer (Lieca 
VT1000 Plus, Leica Microsystems GmbH, Germany). The slices were collected 
in a slice chamber containing recording artificial cerebrospinal fluid (aCSF) 
composed of (in mM): 126 NaCl; 3 KCl; 1.3 MgCl2; 2.5 CaCl2; 26 NaHCO3; 
1.25 NaH2PO4; 11 glucose; 5 HEPES (pH 7.4, when bubbled with 95% O2 and 
5% CO2 and had osmolarity of 305 - 310 mOsmol.). The slices were initially 
maintained at 32 °C for 45 min to recover and transferred to the slice chamber 
kept at room temperature (25 ± 1 °C) until used.  
 
Single-Cell Reverse Transcription-Polymerase Chain Reaction (single-cell 
RT-PCR) 
Single-cell RT-PCR was performed as previously described (Park et al., 
2006). Briefly, under fluorescence microscopy, GAD65-GFP SG neurons and 
DiI labeled STT neurons were verified from the slice prepared. Identified cells 
were harvested into a patch pipette with a tip diameter of about 20 μm, gently 
put into a reaction tube containing reverse transcription reagents, and incubated 
for 1 hour at 50 °C (superscript III, Invitrogen). All PCR amplifications were 
performed with nested primers (Table B). The first round was performed in 20 
μl PCR premix (Bioneer) reaction buffer containing 0.2 μM “outer” primers and 
3 μl RT product. The protocol included 5 min of initial denaturation at 95 °C, 
followed by 35 cycles of 40 s of denaturation at 95 °C, 40 s of annealing at 
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55 °C, and then 40 s of elongation at 72 °C, and was completed with 7 min of 
final elongation. The second round reaction protocol was the same as the first 
round using “inner” primers and 1.5 μl first round products. PCR products were 
then visualized on ethidium bromide-stained, 1.2% agarose gels. 
 
Visualized whole-cell patch clamp recordings 
The slices were transferred to a recording chamber mounted on the stage of a 
BX50WI microscope (Olympus, Tokyo, Japan) fitted with fluorescence optics 
and a 40X water immersion objective. Slices were continuously superfused (~5 
ml/min) with recording aCSF. Wild-type SG neurons, GAD65-GFP SG neurons 
and STT neurons were visualized with fluorescence microscope linked to a 
Luca Andor camera (Andor Technology plc) under control of metaflour 
processing system (Universal Imaging). The data were recorded and acquired 
using an EPC-10 amplifier (HEKA, Germany) and Pulse 8.30 software (HEKA, 
Germany). Identified SG neurons in translucent area of lamina II and visualized 
STT neurons were recorded using microelectrodes of 5 – 8 MΩ pulled from 
borosilicate capillaries (World Precision Instruments) on a Narishige puller (PP-
830, Narishige, Japan). Whole-cell patch clamp recordings were performed at 
Outer primers
β-actin (326 bp, 231 bp) 











Target gene (Product length)a Inner primers                   Genbank No.
Table B. List of DNA primer sequences designed for single-cell RT- PCR.
a (n, n) indicates product size obtained from outer and inner primers, respectively.
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room temperature (25 ± 1 °C). Capsaicin-induced currents were recorded using 
an internal solution containing (mM); 136 K-gluconate; 10 NaCl; 1 MgCl2; 10 
EGTA; 10 HEPES; 2 Mg-ATP; 0.1 Na-GTP (pH 7.33 with KOH, 291 mOsmol) 
and modified aCSF of the following composition (mM): 126 NaCl; 3 KCl; 6 
MgCl2; 0.0 CaCl2; 26 NaHCO3; 1.25 NaH2PO4; 11 glucose; 2 EGTA (pH 7.4, 
when bubbled with 95% O2 and 5% CO2 and had osmolarity of 305 - 310 
mOsmol). To prevent spontaneous synaptic activity, a cocktail of 
neurotransmission inhibitors were added (in µM): 10 CNQX; 50 D-APV, 10 
picrotoxin, 2 strychnine, 0.5 tetrodotoxin. Firing pattern of action potentials, 
resting membrane potential and cell capacitances were measured within 1 min 
after attaining whole-cell configuration. To record evoked excitatory 
postsynaptic currents (EPSCs), SG neurons were held at -70mV and recording 
pipettes were filled with an internal solution containing (in mM); 130 K-
gluconate; 8 NaCl; 0.5 EGTA; 10 HEPES; 4Mg-ATP ; 0.3 Na-GTP; 5 QX-314 
(pH 7.31 with KOH, 270 mOsmol). Electrical stimuli (0.01 ms, 0.066 Hz) were 
delivered through a bipolar, Teflon-coated tungsten electrode, which was placed 
in dorsal root entry zone of spinal cord and monosynaptic EPSCs were 
identified on the basis of the absence of conduction failure of evoked EPSCs. 
To determine the paired-pulse ratio before and after drug application, two 
EPSCs were evoked by a pair of stimuli given at 50 ms intervals (Tominaga et 
al., 1998). The paired-pulse ratio was presented as the ratio of the amplitude of 
the second synaptic response to the amplitude of the first synaptic response. The 
amplitude of evoked EPSCs was measured, four consecutive currents were 
averaged, and these measurements were expressed relative to the normalized 
baseline. To record evoked inhibitory postsynaptic currents (IPSCs) from STT 
neurons, the DiI labeled neurons were held at 0 mV and recording micropipettes 
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were filled with an internal solution containing (in mM); 125 K-gluconate; 4 
NaCl; 0.5 CaCl2; 2 MgCl2; 5 EGTA; 5 HEPES; 4 Na2-ATP; 5 QX-314 (pH 7.38 
with KOH, 283 mOsmol). Electrical stimuli protocol was the same as evoked 
EPSCs recordings. 
 
Western blotting analysis of GluA2 receptors (GluR2) in membrane fraction 
Spinal cord slices (700 μm) were incubated in 95% O2/5% CO2 saturated 
recording aCSF with 5 μM capsaicin for 10 min at 32 °C. After treatment of 
capsaicin, the slices were washed out for 30 min. For subcellular fractionation, 
the spinal cord slices were homogenized in homogenizing buffer containing 10 
mM Tris-HCl, 5 mM EDTA, 300mM sucrose, PIC (Sigma-Aldrich), pH 7.5 on 
ice. The homogenates were centrifuged at 1000 g for 10 min at 4 °C and then 
30% of the supernatant was collected for total protein. After centrifugation at 
20000 g for 20 min at 4 °C, the supernatant (S2) was collected for cytosolic 
proteins. The pellet (P2) was resuspended in homogenizing buffer to obtain 
membrane fraction. Protein concentration was determined with BCA assay kit 
(Pierce) and quantified with a plate reader. Each samples of 50 μg were mixed 
with 6x SDS sample loading buffer followed by boiling for 5 min. After 
measurement of protein concentration using BCA assay, the proteins were 
separated on 5% stacking/8% resolving gels by SDS-PAGE and then transferred 
onto PVDF membrane. The membrane was blocked with 5% BSA or 5% non 
fat skim milk in TBS containing 0.1% Tween20 (TBS-T), pH 7.4 for 1 hour at 
room temperature and subsequently incubated with rabbit anti-GluR2 (Milipore, 
1:1000), rabbit anti-N cadherin (Milipore, 1:10000), mouse anti-β-actin (Sigma, 
1:10000) at 4 °C overnight. The membrane was washed with TBS-T and then 
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incubated with horseradish peroxidase conjugated goat anti-mouse IgG, goat 
anti-rabbit IgG secondary antibody respectively for 1 hour at room temperature. 
After incubation, the membrane was washed with TBS-T then exposed to x-ray 
film by chemiluminescence reagent (West-zol, Intron). For the analysis of the 
visualized band, each band was quantified with Las-1000 (multi Gauge V3.0). 
Independent experiments were repeatedly conducted. 
 
Application of retrograde tracer into VPL region of thalamus 
Experiments were carried out on C57BL/6J (4-week old) male mice as 
previously described (Kim et al., 2009a). Mice were anesthetized with 
pentobarbital sodium (40 mg/kg). After placing a mouse in a stereotaxic 
apparatus (Narishige, Tokyo, Japan), a small scalp cut was made. A hole was 
drilled into the skull to allow the insertion of the needle on a 50 μl Hamilton 
syringe into the target area. Then a red fluorescent dye (1,1′-dioleyl-3,3,3′,3′-
tetramethulindocarbocyanine methanesulfonate [Δ9-DiI], Molecular Probes; 1 
μl, 25 mg/0.5 ml in ethanol) was injected into the region of VPL of the thalamus 
(Bregma: -1.2 ± 0.2 mm, midline: 1.9 ± 0.2 mm, depth: 3.2 ± 0.2 mm) using a 
glass micropipette (20 μm tip diameter). The tracer injection was monitored 
under a stereomicroscope. The incision was closed after the injection. Animals 
were returned to their cages for 5 – 8 days, which was sufficient to permit the 
retrograde tracer to be transported to the soma of the STT neurons. DiI-labeled 
STT neurons were observed in deep lamina of spinal cord.  
 
Chronic constriction injury (CCI) model 
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Mice (6 – 8 weeks old) were anaesthetized by enflurane (4% induction; 2-3% 
maintenance) at 3 L/min in O2 via a face mask. The right thigh was shaved, 
iodine treated and an incision made parallel to the femor. The muscle was 
parted by blunt forcep dissection to expose the sciatic nerve proximal to the 
trifurcation. Two silk sutures (7-0; Ailee Co. Ltd, Busan, Korea) were tied 
loosely around the full circumference of the sciatic nerve 2-3 mm apart and 
secured with a reef knot. Care was taken for the sutures to lie adjacent to but 
not visibly compressing the nerve; intraneural blood flow was not impeded. The 
wound was closed in two layers, with silk sutures (for muscle fascia) and an 
autoclip (for skin). Aseptic conditions were maintained throughout. Surgery was 
performed blind to the treatment-group and genotype of the mice and alternated 
between cages. For reversal of chronic mechanical allodynia, BCTC was 
injected intrathecally 28 days after CCI surgery. 
 
Rectal temperature recording 
Rectal temperature was measured by insertion of a flexible bead probe with 
a digital thermometer (TC-324B, Warner Instrument Corp., Hamden, CT, USA) 
while mice were briefly restrained by the handler; the meter reading was 
equilibrated for 10 s. Temperature recordings were carried out between 12 p.m. 
and 3 p.m. The ambient room temperature was maintained between 22 ~ 24°C. 
Baseline rectal temperature was measured at least twice before dosing and 0.25, 
0.5, 0.75, 1, 1.5, 2 hours after dosing. For intravenous (i.v.) injection mice were 
placed in standard restraining device, tail was swabbed with alcohol and 
injected with 0.04 ml of either drug or vehicle (50% DMSO in sterile saline) 
into the lateral tail vein. The method for intrathecal (i.t.) injection was as for 
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behavior testing (see above). 
 
Drug application 
Capsaicin, AMPA (α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate); 
agonist for AMPA receptor, 6-iodonordihydrocapsaicin; TRPV1 antagonist, D-
AP5; NMDA receptor antagonist, picrotoxin; GABAA antagonist, strychnine; 
glycine receptor antagonist, L-703,606; neurokinin 1 receptor antagonist and 
QX-314; membrane-impermeable Nav channels blocker were purchased from 
Sigma-Aldrich (St. Louis, MO). CNQX; AMPA receptor antagonist; Hexyl-
HIBO; Group I mGluR antagonist, LY341495; Group II mGluR antagonist, and 
TTX; Nav channels blocker were were purchased from Tocris (Buckhurst Hill, 
United Kingdom). BCTC; TRPV1 antagonist was from SK biopharmaceuticals 
(Korea). (RS)-α-methyl-4-carboxyphenylglycine (MCPG); non-selective group 
I and group II mGluR antagonist was purchased from Ascent Scientific (Bristol, 
United Kingdom). Capsaicin was prepared from 10 mM stock solution in 
ethanol and applied using local perfusion system located to 1 - 2 mm from the 
slice. AMPA was delivered through a glass puffer pipette (1 µm tip diameter, 
~10 psi, 69 kPa) using a pneumatic PicoPump (Picospritzer III). The tip of the 
puffer pipette was positioned to a point about 20 - 30 µm from recorded cell 
soma. Cocktail of the inhibitors was applied by superfusion with modified aCSF. 
All drugs exclude above indicated were made as stock solutions and keep at -




I expressed data as mean ± standard error (SEM), unless otherwise indicated. 
Percentages of SG neurons expressing TRPV1 mRNA were compared using a 
Fisher's exact test. Significances in 50% paw withdrawal thresholds in 
comparison with pre-injury levels were calculated by one-way repeated 
measure analysis of variance (ANOVA) followed by Bonferroni’s post-test and 
Student’s unpaired t-test. Mechanical hypersensitivity was calculated by the 
percentage difference in the mechanical thresholds of ipsilateral and 
contralateral hind paws accumulated from each time point up to 28 days after 
CCI. The anti-nociceptive effect of BCTC after intrathecal injection was 
calculated as a percentage of the maximum potential effect (MPE) relative to 
pre-injury baseline threshold. Whole-cell current amplitudes after drug 
application were compared to pre-drug baseline by Student’s paired t-test. 
Expression level of TRPV1 mRNA and protein were compared by Student’s 
unpaired t-test. The data were analyzed and plotted using Origin Pro 8 







Spinal TRPV1 Activation in SG Neurons Produces Mechanical Allodynia 
I first examined the relative contribution of peripheral and central TRPV1 to 
the development of mechanical allodynia induced by the TRPV1 agonist 
capsaicin. Consistent with a recent report (Patwardhan et al., 2009), intrathecal 
administration of capsaicin in mice decreased the paw withdrawal mechanical 
threshold (Figure 14A). This effect was prevented by co-administration of the 
TRPV1-selective antagonist N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl) 
tetrahydropyrazine-1(2H)-carbox-amide (BCTC, Figure 14A). Capsaicin had no 
effect on mechanical thresholds in TRPV1-/- mice (Figure 14B). Intrathecal 
capsaicin could act on either postsynaptic TRPV1 expressed in spinal cord 
neurons or on presynaptic TRPV1 expressed at the primary afferent terminals of 
sensory neurons. To distinguish between these possibilities I generated mice in 
which TRPV1-expressing peripheral neurons are ablated by intraperitoneal 
injection of the ultra-potent TRPV1 agonist resiniferatoxin (RTX). RTX 
treatment eliminated TRPV1 mRNA in dorsal root ganglia without altering 
mRNA levels in the spinal cord (Figure 14C). RTX treatment appeared to be 
effective in completely ablating peripheral neurons expressing TRPV1, 
including their central terminals, because there was complete loss of TRPV1 
immunoreactivity in DRG neurons (Figure 15A and 15B), nearly complete 
(98%) loss of capsaicin-induced calcium increases in DRG cell bodies (Figure 
15D), and complete loss of capsaicin response of presynaptic terminals (Figure 
15C). However, in contrast to TRPV1-/- mice, intrathecal capsaicin injection 
was still able to effectively induce mechanical hypersensitivity in RTX-treated 
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mice (Figure 14B), suggesting a site of action on central neurons. High 
resolution electron microscopic analysis of the lumbar spinal cord revealed 
TRPV1 was localized not only to presynaptic terminals, as expected (Figure 
14D), but also to postsynaptic dendrites in the dorsal horn (Figure 14E), and 
postsynaptic cell soma (Figure 14F). No TRPV1 immunoreactivity was 
observed in the dorsal horn of TRPV1-/- mice (Figure 14G). 
 
TRPV1 Is Functionally Expressed by GABAergic SG Neurons 
I next sought to identify the population of postsynaptic spinal cord neurons 
that functionally express TRPV1. SG neurons of the spinal dorsal horn are a 
heterogenous population of interneurons (Todd and McKenzie, 1989; Maxwell 
et al., 2007) that receive direct inputs from primary afferent fibers (Yasaka et al., 
2007). TRPV1 immunoreactivity was co-localized in postsynaptic dendrites 
with the GABA synthesizing enzyme glutamic acid decarboxylase 65 (GAD65) 
(Figure 16A). TRPV1 mRNA was detected in 76.7% of GAD65-enhanced 
green fluorescent protein (EGFP) positive SG neurons by single-cell RT-PCR 
(Figure 16B, upper). In contrast, the occurrence of TRPV1 mRNA in GAD65-
EGFP negative SG neurons was lower (25%, Figure 16B, lower). To test for 
functional expression of TRPV1, I applied capsaicin (CAP) to spinal cord slices 
while recording from SG neurons. In addition to eliciting spontaneous 
excitatory postsynaptic currents (EPSCs), as expected from activation of 
presynaptic TRPV1 (Figure 17A), capsaicin also elicited clear whole-cell 
currents in SG neurons (Figure 17B) that persisted in the presence of a cocktail 
of neurotransmission blockers including 6-cyano-7-nitroquinoxaline-2,3-dione 
(CNQX), amino-5-phosphonovaleric acid (AP5), picrotoxin, strychnine and 
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tetrodotoxin with high MgCl2 and a calcium chelator (see Materials and 
Methods). Whole-cell capsaicin-induced currents (16.5 ± 2.5 pA) were recorded 
in identified GAD65-positive SG neurons; these currents were blocked by the 
TRPV1 antagonist 6-iodo-nordihydrocapsaicin (6-iodo-capsaicin, 18.70 ± 
1.47%, Figure 16C) and showed outward rectification with a reversal potential 
of ~0 mV characteristic of TRPV1-mediated currents (Caterina et al., 1997) 
(Figure 16D and Figure 17C). A high proportion of these functionally TRPV1-
positive, GAD65-positive SG neurons displayed a long-lasting tonic- or phasic-
firing pattern (Figure 17D) characteristic of inhibitory spinal cord interneurons 
(Cui et al., 2011). These results show that TRPV1 is functionally expressed in a 
substantial subpopulation of GABAergic SG neurons. 
 
Postsynaptic Spinal TRPV1 Mediates LTD via AMPA Internalization in 
GABAergic SG Neurons and Results in Depression of Inhibitory Input to 
Projection Neurons 
I next examined the role of postsynaptic spinal TRPV1 in the spinal cord 
synaptic circuitry involving GAD65-positive SG neurons. Application of 
capsaicin induced a long-lasting depression of EPSCs evoked in SG neurons by 
electrical stimulation of the dorsal root entry zone (DREZ). This effect of 
capsaicin was abolished in slices prepared from TRPV1-/- mice and also when 
intracellular 6-iodo-capsaicin was introduced by the patch pipette (Figure 18A). 
Consistent with a postsynaptic action of capsaicin in LTD, the inclusion of 6-
iodo-capsaicin in the patch pipette did not inhibit spontaneous EPSCs induced 
by presynaptic-TRPV1 activation (Figure 19A). The capsaicin-induced LTD 
persisted in RTX-treated mice (Figure 18B) and capsaicin did not affect the 
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paired-pulse ratio (Figure 18C), suggesting that the LTD is independent of 
TRPV1-expressing afferents and is not mediated by changes in presynaptic 
neurotransmitter release. Capsaicin-induced LTD was not observed when 
intracellular calcium was buffered by 1,2-bis(o-aminophenoxy)ethane-
N,N,N',N'-tetraacetic acid (BAPTA) in the recording pipette (Figure 18B) 
confirming that elevation of postsynaptic of calcium is required for synaptic 
depression by capsaicin. The capsaicin-induced LTD of EPSC was not 
dependent on the activity of NMDA receptors, group I and II metabotropic 
glutamate receptors (mGluR), or the substance P receptor neurokinin 1 as the 
effect was not blocked by application of the antagonists AP5 (50 µM), Hexyl-
HIBO (HIBO, Group I mGluR antagonist, 200 µM), LY341495 (Group II 
mGluR antagonist, 100 µM) (Figure 18B), (RS)-α-methyl-4-
carboxyphenylglycine (MCPG, non-selective group I/group II mGluR 
antagonist, 500 µM) and L-703,606 (10 µM) (Figure 19B), respectively. Thus I 
tested the involvement of alpha-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors as a likely candidate mediating 
TRPV1-dependent synaptic inhibition. I observed that whole-cell currents 
elicited by focal application of AMPA were reduced after capsaicin application 
(68.08 ± 3.39%, Figure 18D); the reduction in AMPA current was not observed 
in the presence of 6-iodo-capsaicin (Figure 19C and 19D). This finding was 
consistent with a postsynaptic locus and suggested altered membrane 
expression of AMPA receptors. Indeed, following capsaicin application to 
spinal cord slices I observed a reduction in membrane expression of AMPA 
receptor subunit GluA2 (GluR2) protein (60.4 ± 9.8%), the main AMPA subunit 
in the SG (Polgar et al., 2008) (Figure 18E).  
 To examine the functional consequences of capsaicin-induced LTD in 
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GABAergic SG interneurons I retrogradely labeled spinothalamic tract (STT) 
projection neurons by injection of 1,1',di-octadecyl-3,3,3'3'-
tetramethylindocarbocyanine perchlorate (DiI) into the ventroposterolateral 
(VPL) subnucleus of the thalamus (Figure 18F). Labeled neurons were located 
in the deep lamina of the spinal dorsal horn and showed inhibitory postsynaptic 
currents (IPSCs) in response to DREZ stimulation (Figure 18F and Figure 20) 
that were blocked by CNQX (10 µM) and AP5 (50 µM), confirming their 
polysynaptic nature. The amplitude of DREZ-evoked IPSCs in STT neurons 
from wild-type (Wt) and RTX-treated mice was decreased after capsaicin 
application, and depression of IPSCs (Wt, 56 ± 11%; RTX-treated mice, 65 ± 
9%) lasted for at least 15 min (Figure 18F). The reduction in IPSC amplitude 
was not the result of a direct action of capsaicin on STT neurons as TRPV1 
mRNA was not detected in STT neurons by single-cell RT-PCR (Figure 18F). 
Together, these data suggest that activation of TRPV1 leads to depression of 
excitatory input to GABAergic SG interneurons by a postsynaptic mechanism 
involving intracellular calcium-dependent GluA2 (GluR2) internalization, thus 
resulting in reduced inhibitory input to STT neurons (Figure 18G). 
 
Postsynaptic Spinal TRPV1 Is Involved in the Maintenance of Chronic 
Mechanical Allodynia after Nerve Injury  
To determine whether activation of spinal TRPV1 plays a role in the 
development of neuropathic pain, I measured mechanical sensitivity in a 
chronic constriction injury (CCI) model. Accumulating mechanical 
hypersensitivity up to 28 days after CCI was attenuated by ~41% in TRPV1-/- 
mice (Figure 21A and 21C) but not in RTX-treated mice (Figure 21B and 21C). 
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Furthermore, spinal TRPV1 inhibition by intrathecal administration of BCTC 
dose-dependently alleviated chronic mechanical pain in RTX-treated mice 
following CCI (Figure 21D and 21E). By restricting TRPV1 blockade to the 
spinal cord CNS using intrathecal injection, we were able to avoid the induction 
of hyperthermia that occurred with systemic (intravenous) administration of 




Figure 14. Spinal TRPV1 in central neurons mediates 
mechanical allodynia 
 
(A, B) Mechanical thresholds were measured after intrathecal administration of 
capsaicin. (A) Time course after injection of capsaicin (1 μg, n = 6), capsaicin 
(1 μg) with BCTC (10 μg, n =6) and vehicle with BCTC alone (10 μg, n = 5) in 
naïve mice. (B) Time course after injection of capsaicin (1 μg) in TRPV1-/-(n = 
5) and RTX-treated mice (n = 6). One-way repeated measures ANOVA of 
changes in mechanical threshold by capsaicin, *P<0.05, **P<0.005. (C) 
Expression level of TRPV1 mRNA was markedly decreased in dorsal root 
ganglion but not in spinal cord (n = 3, unpaired t-test; **P<0.001) 7 days after 
intraperitoneal injection of RTX. (D-G) Electron microscopic immunostaining 
for TRPV1 in the superficial lamina of the spinal dorsal horn in naïve (D-F) and 
TRPV1-/- mice (G). (D) TRPV1 immunostaining is observed in an axon 
terminal containing spherical vesicles that is presynaptic to a dendrite, (E) in a 
dendrite that is postsynaptic to an axon terminal and (F) within somata (inset; 
higher magnification of boxed area). (G) TRPV1 immunostaining is completely 
abolished in the spinal dorsal horn of the TRPV1-/- mice. Arrow indicates 
TRPV1 immunoreaction product. At, axon terminal; d, dendrite. Scale bar, 200 







Figure 15. Expression of TRPV1 in the spinal cord and 
DRG of adult mice 
 
(A) Photomicrographs showing immunoreactivity for TRPV1 in the spinal 
dorsal horn of wild-type (upper left), TRPV1-/- (lower left), vehicle-treated 
(upper right) and RTX-treated mice (lower right). TRPV1 immunostaining is 
observed in the superficial lamina of the spinal dorsal horn of the wild-type and 
vehicle-treated mice, while immunostaining is absent from the dorsal horn of 
the TRPV1-/- and RTX-treated mice. Scale bar, 200 µm. (B) Photomicrographs 
showing immunoreactivity for TRPV1 in the dorsal root ganglion (DRG) of 
naïve (left) and RTX-treated mice (right). (C) Application of capsaicin (2 µM) 
increased the frequency of spontaneous EPSCs in SG neurons from wild-type 
(Wt, left) mice, but not from RTX-treated mice (right). (E) Histogram showing 
percentage of DRG neurons responding to capsaicin with [Ca2+]i transients in 
Wt and RTX-treated mice. Neurons were confirmed by their response to high 









Figure 16. TRPV1 is functionally expressed by GAD-
positive SG neurons 
  
(A) Electron micrograph of immunoperoxidase staining for TRPV1 combined 
with immunogold labeling for glutamic acid decarboxylase (GAD) in spinal 
dorsal horn of mice. TRPV1 (arrow) and GAD (arrow head) were detected in 
the same dendrites. Scale bar, 500 nm. (B), Single-cell RT-PCR revealed that 
TRPV1 mRNA was expressed predominantly in a population of GAD65-EGFP 
positive SG neurons (n = 23/30) but in also in a small population of GAD65-
EGFP negative SG neurons (n = 5/20, ***P=0.0005, Fisher's exact test). (C, D) 
Functional expression of TRPV1 in GAD65-EGFP positive SG neurons. (C) 
Capsaicin (CAP, 2 μM)-induced currents were blocked by 50 μM 6-
iodonordihydrocapsaicin (6-iodo-CAP, n = 6, *P=3.61e-8). (D) I–V relationship 





Figure 17. Functional expression of TRPV1 in tonic- 
and phasic-firing postsynaptic SG neurons 
 
(A-C) Capsaicin (2 μM, CAP)-induced inward currents were elicited at -70mV 
of holding potential in normal aCSF (A) and in modified aCSF with a cocktail 
of neurotransmission blockers (B). I-V relationship (-90 mV to +40mV, 500 
ms) obtained from CAP-induced currents (C). I-V relationship indicated that 
CAP-induced currents have the characteristics of TRPV1-mediated currents 
with a reversal potential of ~0 mV and slight outward rectification. (D) Patterns 
of action potential discharge were determined by 200 pA currents injection for 
2 s into GAD65-GFP SG neurons that showed CAP-induced inward currents. 
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Figure 18. Capsaicin-induced LTD via reduction of 
membrane GluA2 (GluR2) in GAD-positive SG neurons 
results in depression of inhibitory input to STT neurons 
in spinal cord. 
 
(A) CAP (2 μM for 5 min) induced LTD of eEPSCs (Vh = -70 mV, n = 9) in 
GAD65-EGFP positive SG neurons that was blocked by intra-pipette 6-iodo-
CAP (50 μM, n = 5) and was absent in TRPV1-/- mice (n = 5). (B) CAP-induced 
LTD was blocked by internal administration of calcium chelator, 1,2-bis(o-
aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA, 10 mM, n = 6), but 
not by amino-5-phosphonovaleric acid (AP5, NMDA-R blocker, 50 µM, n = 8) 
or Hexyl-HIBO (HIBO, Group I mGluR antagonist, 200 µM) with LY341495 
(Group II mGluR antagonist, 100 µM) (n = 7). Administration of CAP 
consistently induced LTD in RTX-treated mice (n = 6). (C) Paired pulse ratio 
was obtained by a pair of stimuli given at 50 ms intervals (n = 7). (D) AMPA-
induced currents were elicited by 100 μM AMPA puffing (20 - 200 ms, 3 min 
interval repeated puffing) at -70 mV holding potential. Bath application of 
capsaicin (2 μM, 5 min) decreased AMPA-induced currents (n = 6, *P=2.27e-
4). (E) GluA2 receptors (GluR2) in membrane fraction was reduced by CAP (5 
μM for 10 min and washout for 30 min) in lumbar spinal cord of wild-type 
mice, but not in TRPV1-/- mice (n = 3, for each group, *P=0.016). (F) Single-
cell RT-PCR revealed no mRNA expression of TRPV1 in spinothalamic tract 
(STT) neurons. In STT neurons from both wild-type (Wt) and RTX-treated 
mice, evoked IPSCs at 0 mV following stimulation of dorsal root entry zone 
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(DREZ) were reduced by CAP (2 μM for 5 min and washout for 10 min, Wt; n 
= 6, RTX; n = 7, One-way ANOVA, Bonferroni’s test; *P<0.05 (Control vs Wt-
CAP or RTX-CAP group), n.s. (Wt-CAP vs RTX-CAP group). (G) Schematic 
representation of TRPV1 activation in GABAergic SG neurons and 
hypothesized sequence of events for the genesis of pain hypersensitivity 
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Figure 19. Activation of postsynaptic TRPV1 induces 
AMPA receptor internalization 
 
(A) Application of 6-iodo-capsaicin in the patch pipette did not inhibit 
spontaneous EPSC induced by presynaptic activation of TRPV1. (B) CAP (2 
μM for 5 min) induced LTD of eEPSCs in GAD65-EGFP positive SG neurons 
was not blocked by amino-5-phosphonovaleric acid (AP5, NMDA-R blocker, 
50 µM) with (RS)-α-methyl-4-carboxyphenylglycine (MCPG, non-selective 
group I/group II mGluR antagonist, 500 µM) (n = 6) or L-703,606 (neurokinin 
1 receptor antagonist, 10 µM, n = 6). (C) AMPA-induced currents were elicited 
by 100 μM AMPA puffing (20 - 200 ms, 3 min interval repeated puffing) at -70 
mV of holding potential. Bath application of CAP did not reduce AMPA-
induced currents in the presence of 50 μM 6-Iodo-CAP (97.91 ± 1.18% of 









































































Figure 20. Inhibitory postsynaptic currents (IPSCs) are 
evoked by dorsal root entry zone (DREZ) stimulation in 
Dil-labled spinothalamic tract (STT) neurons 
 
(A) In Dil-labled STT neurons, evoked IPSCs at 0 mV following stimulation of 
DREZ were completely abolished in the presence of 5 μM picrotoxin and 2 μM 
strychinine, which indicate that IPSCs were not contaminated with glutamate-
induced EPSCs. (B) The DREZ evoked IPSCs in STT neurons were also 
blocked by CNQX (10 µM) and AP5 (50 µM), suggesting that IPSCs evoked 
following DREZ stimulation were poly-synaptic and not a result of direct 
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Figure 21. Chronic mechanical allodynia by nerve 
injury is alleviated by blockade of postsynaptic TRPV1 
in spinal cord 
 
(A, B) Changes in the mechanical thresholds after sciatic nerve chronic 
constriction injury (CCI) were measured in TRPV1+/+, TRPV1-/-, vehicle-treated 
and RTX-treated mice (n = 6 for each group). One-way repeated measures 
ANOVA followed by Bonferroni’s test; **P<0.001 (naïve mice), #P<0.05, 
##P<0.001 (TRPV1-/- mice vs. Presurgical value (-1 day), t-test; Ψ P<0.05 
(naïve vs TRPV1-/- or vehicle-treated vs RTX-treated). (C) Mechanical 
hypersensitivity was calculated as the percentage difference in the mechanical 
thresholds of ipsilateral and contralateral hind paws accumulated from each 
time point up to 28 days after CCI (n = 6 for each group). One-way ANOVA 
followed by Bonferroni’s test; *P=0.0051 (Wt vs TRPV1-/-). (D) Intrathecal 
injection of BCTC in RTX-treated mice reversed chronic mechanical 
hypersensitivity at 28 days after CCI in a dose-dependent manner (n = 6 for 
each group). (E) The data were normalized and displayed as the maximum 
possible effect (MPE). Two-way ANOVA, Bonferroni’s test; *P<0.05, 
**P<0.01. (F) Rectal body temperature measured after intravenous (i.v.) 
injection of BCTC (3 mg/kg) or vehicle only (50% DMSO in saline) compared 
with high dose intrathecal (i.t.) injection of BCTC (100 µg). (n=4 mice per 


































































































































i.t.  BCTC (100 μg)
i.v. Vehicle










































Figure 22. Spinal-TRPV1 activation by 12(S)-HPETE 
produces mechanical allodynia 
 
Mechanical threshold was measured after intrathecal administration of 12(S)-
HPETE (1 μg, n = 8), 12(S)-HPETE (1 μg) with BCTC (10 μg, n = 9) and 
BCTC alone (10 μg, n = 5) in naïve mice. One-way repeated measures ANOVA 
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I have shown that activation of postsynaptic spinal TRPV1 leads to 
decreased functional AMPA receptor expression in GABAergic SG interneurons 
and thus reduced excitation of a key population of inhibitory interneurons. The 
observation of reduced inhibitory synaptic signaling to STT neurons of the deep 
lamina suggests a novel mechanism of ‘disinhibition’ of spinal cord projection 
neurons that are critical for the relay of nociceptive signals to higher brain 
centers. Using the sciatic nerve CCI model in TRPV1-/- mice I uncover for the 
first time a substantial role of TRPV1 in neuropathic mechanical pain. 
Furthermore, I reveal that endogenous activation of spinal TRPV1, possibly by 
GPCRs (Kim et al., 2009b) or arachidonic acid (AA) metabolites (Gibson et al., 
2008) such as 12-hydroperoxyeicosatetraenoic acid (12-HPETE)  (Figure 22) 
contributes to the maintenance of chronic mechanical allodynia after 
neuropathic nerve injury. I observed around a 40% reversal of CCI-induced 
mechanical allodynia by spinal application of the TRPV1 antagonist BCTC in 
RTX-treated mice (Figure 17D and 17E), a value comparable with a previous 
report on gabapentin (Pedersen et al., 2005). My observations also correlate 
with findings showing that TRPV1 antagonists with greater CNS penetration 
are more potent for reducing mechanical allodynia (Cui et al., 2006; 
Patapoutian et al., 2009). Finally, I have shown that by targeting spinally-
mediated chronic pain we can avoid the side effects of peripheral TRPV1 
blockade on temperature homeostasis (Steiner et al., 2007).  
Our results help to clarify prior controversy surrounding the role of TRPV1 
by explaining how it is that TRPV1 antagonists can reduce neuropathic 
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mechanical pain (Cui et al., 2006; Patapoutian et al., 2009) even though 
TRPV1-expressing primary sensory neurons do not convey physiological 
mechanical pain (Cavanaugh et al., 2009). A recent study using a TRPV1 
reporter mouse showed that there are very few cells in the CNS that express 
TRPV1 (Cavanaugh et al., 2011); the results using both immuno EM and 
electrophysiology show that a subpopulation of interneurons in the substantia 
gelatinosa are among these. The TRPV1-mediated currents in these SG neurons 
were small (~17 pA on average), corresponding to activation of only a few 
dozen TRPV1 channels. Nevertheless, I find that this sparse expression of 
postsynaptic TRPV1 channels in a key population of neurons has major 
functional consequences, playing a critical role in mediating mechanical 
allodynia. 
Together with TRPV1-mediated synaptic plasticity recently demonstrated in 
hippocampus (Gibson et al., 2008), dentate gyrus (Chavez et al., 2010) and 
nucleus accumbens (Grueter et al., 2010) this work provides further evidence 
for the functional significance and physiological implications of TRPV1 in the 
CNS. In particular, the present study demonstrates that TRPV1 expression in a 
key population of spinal cord neurons underlies a critical role as modulator of 
pain transmission in spinal circuits distinct from its well-known role as a 
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척수 통증과민화에서 중추  
transient receptor potential vanilloid-1  
수용체의 역할 
 
Transient receptor potential vanilloid subtype 1 (TRPV1) 수용체는 C-섬
유 일차구심성 신경세포의 중추 말단에 주로 발현되며 그 길항제는 
염증성 통증과 신경병증성 통증의 완화에 영향을 준다. 말초신경말단
에서 TRPV1 과 metabotropic glutamate receptor 5 (mGluR5)에 의한 통증 
감작 및 그 조절 현상이 제시되었지만 척수 신경으로 유입되는 감각
신경세포의 중추말단에 발현된 mGluR5와 TRPV1에 대한 기능적 발현 
및 역할에 대해 아직 많이 알려져 있지 않다. 이번 연구를 통해 말초
신경의 중추 말단에서 활성화된 mGluR5에 의해 생성된 diacylglycerol 
(DAG)를 통한 TRPV1의 활성화 기전을 증명함으로써 mGluR5-TRPV1
의 기능적 상호작용이 병적 상황에서 중추신경과민화 형성에 중요한 
역할을 하고 있음을 보여주었다. 
또한 말초신경에 발현되어있는 TRPV1이 기계적 이질통 형성에 관
여하지 않는 것으로 알려져 있지만 실제로 TRPV1의 길항제를 투여시 
열 통각과민화뿐 아니라 기계적 이질통이 완화됨이 보고되었다. 이는 
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중추 신경에 발현되어 있는 TRPV1이 병적인 기계적 이질통 형성에 
관여할 수 있음을 시사한다. 하지만 병적 상황에서 중추신경세포에 
발현된 TRPV1의 역할 및 작용 기전은 거의 밝혀지지 않았다. 이러한 
이유로 본 연구자는 척수신경세포에 발현된 TRPV1 역할을 알아보았
다. TRPV1은 척수 substantia gelatinosa 지역의 GABAergic 억제성 신경
세포에 발현되어 있고 그 활성화로 인해 long-term depression (LTD)이 
형성됨을 확인 할 수 있었다. 이러한 억제성 척수신경세포의 LTD는 
척수 내 통증 전달 경로의 마지막 관문인 projection 신경세포에 억제
성 신호를 감소 시킴으로써 기계적 이질통 형성에 영향을 주는 것을 
증명하였다. 또한 마지막으로 신경손상에 의한 만성 기계적 이질통이 
척수 내 TRPV1 길항제 투약으로 인해 억제됨을 확인함으로써 TRPV1
이 중요한 시냅스 조절자로 역할을 할 뿐 아니라 중추신경 특이적 
TRPV1 길항제의 사용을 통해 신경병증성 통증을 치료할 수 있는 가
능성을 제시하였다.       
______________________________________________________ 
주요어: TRPV1, mGluR5, diacylglycerol, long-term depression, substantia 
gelatinosa, disinhibition, 중추신경과민화, 신경병증성 통증 
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